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AMP Adenosine 5'-monophosphate 
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pNPP p-nitrophenyl phosphate 
K Michaelis constant 
m 
AQ ^  Activation constant 
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KF Potassium fluoride 
LDH Lactate dehydrogenase 
7o GSI (7oI) Percent of glycogen synthase independent form 
U International units of enzyme 
DTNB 5,5'-Dithiobis(2-nitro-benzoic acid) 
NADH Reduced 0-nicotinamide adenine dinucleotide 
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GENERAL INTRODUCTION 
Properties of Mammalian Glycogen Synthases 
Inconver tible forms 
Glycogen synthase^ , the rate-limiting enzyme of glycogen synthesis 
in mammalian systems, catalyzes the transfer of glucosyl moiety from 
UDP-glucose to the nonreducing ends of the existing glycogen primers. 
It was first described in liver extracts by Leloir and Cardini (1). 
In early studies, Leloir et al. (2) discovered that glucose-6-P stimu­
lated glycogen synthase-catalyzed glycogen synthesis in skeletal muscle 
extracts. Villar-Palasi and Larner (3-5) observed that the degree to 
which the activity of the enzyme could be stimulated by glucose-6-P de­
pended on the metabolic state of the cell, and suggested that skeletal 
muscle glycogen synthase existed as two separable enzyme forms. The 
two forms of glycogen synthase were later confirmed in other mammalian 
tissues, i.e., in liver (6, 7), in adipose tissue (8-10), in kidney (11), 
in heart (12, 13), in leucocytes (14, 15), in brain (16), in spleen 
(17), and in many other tissues. The two forms of glycogen synthase 
are rapidly interconvertible in vivo. The interconversion involves 
phosphorylation-dephosphorylation reactions (18-20) similar to the 
2 
reactions of glycogen phosphorylase , the key enzyme in glycogenolysis 
(21-24). Phosphorylation of glycogen synthase inactivates the enzyme 
(25-27); whereas phosphorylation of glycogen phosphorylase leads to 
enzyme activation (21, 28). Therefore, phosphorylation-dephosphorylation 
HjDP-glucose:glycogen a-l,4-glycosyltransferase, EC 2.4.1.11. 
2 
a-1,4-Glucan:orthophosphate glycosyltransferase, EC 2.4.1.1. 
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reactions play a dual role in regulation of glycogen metabolism (for re­
views , see references 29-32). 
Dephosphorylated glycogen synthase (glycogen synthase I) is the 
physiologically active form of the enzyme. The phosphorylated form 
(traditionally known as glycogen synthase D) is less active without 
glucose-6-P (19). Both forms of glycogen synthase have been exten­
sively studied in many mammalian tissues (31). Both phospho- and 
dephospho- forms of glycogen synthase have been purified to homogeneity 
as judged by SDS-polyacrylamide gel electrophoresis from rabbit skeletal 
muscle (33-35), rat liver (36-38), bovine cardiac tissue (39, 40) and 
human leucocytes (41, 42). Homogeneous preparations of phosphorylated 
glycogen synthase were also obtained from swine kidney (43) and swine 
adipose tissue (44). The reported specific activities of the purified 
enzymes varied from 1.9 U/mg for swine adipose tissue phosphorylated 
glycogen synthase (44) to about 30-40 U/mg for rabbit skeletal muscle 
(35) and bovine cardiac muscle glycogen synthases (40). Jett and 
Soderling (38) have recently reported that their preparation of rat 
hepatic phosphorylated glycogen synthase had a specific activity of over 
50 U/mg. 
Molecular structure of the enzymes 
There is now general agreement that both forms of glycogen synthase 
exist as oligomeric proteins (33-45) and they are composed of subunits 
of uniform size with a molecular weight of 85,000 to 90,000 as judged 
by gel electrophoresis in the presence of SDS (33-48). The aggregation 
of skeletal muscle dephosphorylated glycogen synthase is temperature-
3 
dependent (49). Phosphorylated glycogen synthase from skeletal muscle 
(39), liver (36, 50), cardiac muscle (51), kidney (43), and human 
leucocytes (41) exhibits various molecular weight forms. Phosphorylated 
glycogen synthase may exist as the dimer (50-53), trimer (34-36, 50), 
tetramer (35, 41, 43, 51, 52, 54), and hexamer (36, 51). Dephosphory-
lated glycogen synthase from rabbit skeletal muscle, bovine cardiac 
muscle and human leucocytes may also exist as the dimeric (33, 35, 55), 
tetrameric (35, 46, 55, 56) and the hexameric (46, 55) forms; but the 
majority of the enzyme is tetrameric. 
Many metabolites, including glucose-6-P, UDP-glucose, and ATP 
have important effects on the molecular structure of skeletal muscle 
and liver glycogen synthases (49, 50, 57). The first three metabolites 
apparently cause the aggregation of hepatic enzyme from the dimeric to 
the trimeric species, and ATP reverses this effect (50, 57). Redder 
(51) recently made the observation that glucose-6-P causes the dissocia­
tion of cardiac phosphorylated glycogen synthase from a tetrameric form 
to a dimeric species. The effect of glucose-6-P was pS-dependent and 
occurred at pH 6.5 but not pH 7.5. 
Effectors of enzyme activity 
The enzyme activity of all forms of glycogen synthase is subjected 
to allosteric regulation by a number of metabolites although each form 
differs in their sensitivities. All forms of glycogen synthase (8, 
58-62) are affected allosterically by nucleotides, inorganic phosphate 
and glucose-6-P, Nucleotide inhibition of glycogen synthase activity 
may be either directly competitive with UDP-glucose, the physiological 
4 
substrate (8, 59, 60, 62) or cooperative as suggested by Piras et al. 
(60) and Nakai and Thomas (62). Inorganic phosphate inhibits phosphory-
lated forms of glycogen synthase (58, 59, 62), but activates dephos-
phorylated glycogen synthase (39). Activation by glucose-6-P apparently 
affects the K for UDP-glucose (58, 59, 61). Sulfate ion has been found 
m 
to counter the effects of glucose-6-P, ATP, and other effectors that 
could be found in tissue homogenates (61). Inclusion of sodium sulfate 
in the assay for enzyme activity in the absence of glucose-6-P is con­
sidered by some workers a more reliable measure of the amount of the 
dephosphorylated form present in a glycogen synthase preparation than 
that without it (45, 61, 63). Increasing alkaline-labile phosphate 
content in the enzyme increases the effects of activators and inhibitors 
on enzyme (64). The for UDP-glucose and the A^  ^  for glucose-6-P 
are both functions of the phosphorylation state of the enzyme (45). 
Both parameters increase with increasing phosphate content with the 
greatest changes occurring with more than two phosphates per subunit 
(65). Furthermore, the sensitivity of the enzyme to sulfate activation 
increases markedly with increasing phosphorylation state of the enzyme 
(45, 65). It is, therefore, suggested that glycogen synthase activity 
is regulated by a combination of kinetic effectors and the covalent 
modification. 
Because a good correlation exists between the phosphorylation state 
of the enzyme and its activity ratio (the ratio of enzyme activity 
assayed in the absence of glucose-6-P to that measured in the presence 
of a saturated amount of the activator (38, 45, 66, 67)), the activity 
ratio of the enzyme has been used to measure the phosphorylation state 
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of the enzyme. Recent evidence revealed that the direct relationship 
between these two parameters was lost when the enzyme was highly phos-
phorylated (i.e., more than two phosphates per subunit). The same was 
also true when the enzyme was phosphorylated by more than one kind of 
kinase (45, 68, 69). As a result, it has been suggested that activity 
ratio alone may not be sufficient to define the phosphorylation state 
of the phosphorylated glycogen synthase. It has also been proposed 
(55, 64, 65, 70) that a more reliable index of the phosphorylation 
state of glycogen synthase is the  ^for glucose-6-P value. Conse­
quently, several alternative assays, including different concentrations 
of glucose-6-P and/or a low concentration of TJDP-glucose (71-73), have 
been suggested to replace the traditional activity ratio. 
Phosphorylation of Glycogen Synthase 
Early studies by Belocopitow (25) demonstrated that glycogen 
synthase in rat diaphragms was inactivated by treating the tissue with 
epinephrine or by adding cAMP to the broken-cell preparations. The 
cAMP stimulation of the conversion of glycogen synthase I to D was 
later confirmed in skeletal muscle (19, 74, 75). Huijing and Larner 
(76) established that the inactivation of glycogen synthase was 
stimulated directly by cAMP but not by other metabolites. Friedman and 
Larner (19) reported that conversion of glycogen synthase I to D in the 
32 presence of P-labelled ATP at the y-position led to the incorporation 
of radioactivity into the enzyme; and the reconversion of glycogen 
synthase D to I corresponded to the release of radioactivity from the 
6 
32 [ P]-labelled glycogen synthase D. Their data suggested that the inter-
conversion was a result of protein phosphorylation-dephosphorylation. 
They also reported that the kinase that catalyzed the phosphorylation 
3 
was not phosphorylase kinase (77). Walsh et al. (78) later identified 
and purified a protein kinase, called cAMP-dependent protein kinase'^ , 
that phosphorylated and subsequently activated phosphorylase kinase. 
It was also reported that the inactivation of glycogen synthase and 
activation of phosphorylase kinase were both inhibited by the same heat 
stable protein isolated from skeletal muscle (27); this heat stable 
protein was later purified and identified as cAMP-dependent protein 
kinase inhibitor (79). Schlender et al. (80) suggested that the kinase 
that converted glycogen synthase I to D was cAMP-dependent protein 
kinase. Subsequent work confirmed their claim (33, 81). It is now well-
established that cAMP-dependent protein kinase is capable of phosphory-
lating a number of protein substrates, including phosphorylase kinase 
and glycogen synthase; nevertheless, its site specificity remains rather 
stringent (82-87). cAMP-dependent protein kinase exist as at least two 
isozymes in cells. There are many excellent reviews on the cAMP-
dependent protein kinases in the literature (30, 32, 88-90). 
In contrast to the situation for glycogen phosphorylase in which 
there is only a single phosphorylation site per subunit, glycogen syn­
thase has multiple phosphorylation sites in each subunit. Smith et al. 
(34) reported that rabbit muscle enzyme contained six alkali-labile 
3 ATP:phosphorylase phosphotransferase, EC 2.7.1.38. 
4 
ATP:protein phosphotransferase, EC 2.7.1.37. 
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phosphorylation sites in each 90,000 daltons subunit. Because only one 
phos phoryla ted peptide sequence was identified for the skeletal muscle 
enzyme at that time, it was speculated that six small 15,000 daltons 
fragments containing one phosphorylation site per fragment together form 
the larger 90,000 daltons subunit (13). Alternatively, it was also sug­
gested that glycogen synthase was multiply phosphorylated (34). Later 
evidence eventually established the concept of multiple phosphorylation 
(65, 66, 91, 92). In fact, it has even been reported as many as twelve 
phosphorylation sites in each 85,000 daltons subunit of rat hepatic 
enzyme (36). Recently, the amino acid sequence of most of the phos­
phorylation sites for the muscle enzyme has been reported (93-96). 
It is now generally accepted that glycogen synthases from many mammalian 
sources are multiply phosphorylated. 
Phosphorylation by cAMP-dependent protein kinase 
Phosphorylation of glycogen synthase by cAMP-dependent protein 
kinase has been studied extensively in recent years. It has been re­
ported that both protein kinase and ATP concentration affected the 
number of phosphates incorporated in each skeletal muscle glycogen 
synthase subunit. A low concentration (10 ^  M) of cAMP-dependent 
protein kinase put one mole of phosphate in each of the glycogen syn­
thase subunit, resulting in a partially glucose-6-P dependent species 
(97, 98). Higher concentration of the kinase (10 ^  to 10 ^  M) can 
incorporate up to five or six phosphates per subunit (34, 98). Recently, 
Mitchell et al. (40) reported that phosphorylation of bovine cardiac 
glycogen synthase by cAMP-dependent protein kinase incorporated two 
8 
phosphates per subunit. These two phosphates were put at two distinct 
32 
sites according to SDS-gel electrophoresis of the [ P]-labelled cyanogen 
bromide peptides. At 10 yM ATP, only one of these sites was phosphory-
lated by cAMP-dependent protein kinase, and the resulting enzyme was 
half inactivated. Incorporation of the second phosphate required a 
higher concentration of ATP or ITP. ITP was not a phosphoryl donor, 
implying that there may be control of the second-site phosphorylation 
by the nucleotide triphosphates. 
Proud et al. (94) reported that when muscle glycogen synthase, 
phosphorylated by cAMP-dependent protein kinase, was digested with 
trypsin, two phosphorylated tryptic peptides were obtained. The 
stoichiometry indicated incorporation of only one phosphate per sub-
unit. By comparing the amino acid sequences of the phosphorylation 
sites, they concluded that these two labelled peptides were derived 
from two distinct sites. Soderling (98) reported that phosphorylation 
of skeletal muscle glycogen synthase by cAMP-dependent protein kinase 
incorporated only two phosphates in each synthase subunit. These two 
phosphorylation sites could be differentiated by trypsinization of 
glycogen synthase which reduced its subunit molecular weight from 90,000 
to about 73,000 (56), One of the phosphorylation sites remained in 
the trichloroacetic acid-insoluble fragment and has been referred to as 
the "trypsin-insensitive" site. The other site was in the trichloro­
acetic acid-soluble low molecular weight peptide, and was designated 
as "trypsin-sensitive" site (56). Proud et al. (94) and Huang and 
32 Krebs (95), however, demonstrated the presence of two major [ P]-
peptides derived from the trypsin-sensitive region. The amino acid 
9 
sequences for these peptides have also been worked out (94, 95). Huang 
and Huang (99) analyzed the cAMP-dependent protein kinase phosphorylated 
tryptic peptides by isoelectric focusing on polyacrylamide gel in the 
32 presence of urea. They detected the presence of two [ P]-peptides. On 
the other hand. Brown at al. (100) reported that cAMP-dependent protein 
kinase put three phosphates in each subunit of rabbit skeletal muscle 
glycogen synthase in order to completely inactivate the enzyme. The 
incorporation of the first phosphate had very little effect on the 
enzyme; and this first phosphorylation site was then referred to as the 
"silent site." 
Phosphorylation by cAMP-independent protein kinases 
Glycogen synthase from many mammalian sources can be phosphorylated 
by many other protein kinases besides the cAMP-dependent protein kinases. 
Several reports have clearly demonstrated that there are protein kinase 
activities, distinct from the cAMP-dependent protein kinase, capable of 
phosphorylating and subsequently inactivating glycogen synthase (45, 
66-69, 91, 97, 101-106). These protein kinase activities, which are 
not affected by cAMP nor inhibited by the heat stable cAMP-dependent 
protein kinase inhibitor, are collectively termed cAMP-independent 
protein kinases. Some of these kinases phosphorylate other protein 
substrates, such as casein and phosvitin (66, 68, 69, 103-106) in ad­
dition to glycogen synthase, while the others are rather specific for 
glycogen synthase (45, 67). It is still not clear if the casein and 
phosvitin kinase activities are the ^  novo properties of these kinases 
or if they are only contaminating activities which copurify with the 
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glycogen synthase kinases. The cAMP-independent protein kinases were 
reported to incorporate one (45, 66, 68, 101), two (105, 106) or four 
(67, 69, 104, 106) phosphates into each subunit of glycogen synthase. 
Huang and coworkers (67, 69, 104), however, reported that only two of 
the four phosphates incorporated by their preparation of kinase were 
important in the determination of glucose-6-P dependence. The reported 
for ATP for these independent kinase-catalyzed glycogen synthase 
phosphorylation ranged from 12 pM (69, 106) to 0.4 mM (45, 101); 
whereas the for ATP for the cAMP-dependent kinase-catalyzed reactions 
were about 10 p-M (40, 107). Several "homogeneous" preparations of 
glycogen synthase were found to be contaminated with the independent 
kinase activities (101). It is possible that many of the previous 
studies on the glycogen synthase phosphorylation by cAMP-de pendent 
protein kinase might have been complicated by contaminating kinase 
activities. Cohen (90) suggested that cAMP-dependent protein kinase-
mediated glycogen synthase phosphorylation can be studied independently 
of the cAMP-independent protein kinase-catalyzed phosphorylation by 
using a low ATP concentration (0.1 mM) and a low free Mg"*"*" concentration 
because the cAMP-independent reactions require higher concentrations of 
ATP and free In spite of the fact that regulators of cAMP-
independent protein kinases have not been identified, the abundance of 
these kinases among various tissues (102) suggests that they may have an 
important role in the regulation of glycogen synthase activity in cell. 
Furthermore, studies of glycogen synthase phosphorylation states in 
mammalian cell lines that lack cAMP-dependent protein kinase strongly 
suggested an important role for the cAMP-independent protein kinases 
11 
in the regulation of the phosphorylation state of glycogen synthase 
in vivo (108, 109). 
Phosphorvlation by phosphorvlase kinase 
Early studies suggested that phosphorylase kinase did not phos-
phorylate (101) or inactivate (77) glycogen synthase, but recent studies 
by Roach et al. (110) suggested otherwise. They reported that rabbit 
skeletal muscle glycogen synthase could be phosphorylated by phosphory­
lase kinase isolated from the same source. The phosphorylase kinase-
mediated glycogen synthase phosphorylation incorporated 0.6-0.8 mol/mol 
of enzyme subunit preferentially into a single cyanogen bromide fragment 
of glycogen synthase. The phosphorylation site was clearly different 
from the sites phosphorylated by cAMP-dependent protein kinase. This 
phosphorylase kinase-mediated glycogen synthase phosphorylation in 
skeletal muscle was later confirmed in several other laboratories (111-
113). This reaction, which was stimulated by calmodulin (113, 114), 
only led to a partial inactivation of glycogen synthase. Although 
Srivastava et al. (115) demonstrated a calcium-dependent inactivation 
of glycogen synthase and a simultaneously activation of glycogen phos­
phorylase in an isolated glycogen-protein complex from rabbit skeletal 
muscle, and although the idea of regulation of glycogen synthase by the 
phosphorylation reaction catalyzed by phosphorylase kinase could provide 
a mechanism for Ca"^  involvement in the regulation of glycogen metabolism, 
the role of phosphorylase kinase in the regulation of glycogen synthase 
activity remains uncertain. By itself, phosphorylase kinase was not 
12 
able to fully inactivate glycogen synthase, and the reaction has not 
been demonstrated in tissues other than skeletal muscle. 
Phosphorylation by Ca -dependent glycogen synthase kinase 
Payne and Soderling (116) recently isolated a calmodulin-dependent 
kinase from rabbit liver, which was able to phosphorylate glycogen 
synthase in vitro. This kinase, unlike other independent kinases, was 
completely dependent on the presence of calmodulin and Ca for activity. 
Its activity was completely abolished when EGIA. was included. It was 
rather specific for glycogen synthase, and did not phosphorylate phos-
phorylase b. Like phosphorylase kinase, it rapidly incorporated only 
0.4-0.5 moles of phosphate in each mole of glycogen synthase subunit, 
resulting in only partial inactivation of the enzyme. The physiological 
significance of this kinase is still in doubt because the substrates, 
glycogen synthase and phosphorylase, in their study were isolated from 
skeletal muscle despite the fact that their kinase was isolated from 
liver. 
Physiological significance 
Although the in vitro studies of glycogen synthase phosphorylation 
reactions have been examined with great detail, there has been ex­
tremely limited investigation in vivo. McCullough and Walsh (117) 
have attempted to study glycogen synthase phosphorylation in vivo 
with perfused rat hearts. An immunoprecipitation technique was used 
32 to isolate [ P]-labelled glycogen synthase from the tissue. They 
32 
could identify two or three [ P]-labelled cyanogen bromide peptides 
from this enzyme. The same major peptides could also be obtained when 
13 
purified rat heart or rabbit skeletal muscle glycogen synthase was 
32 phosphorylated by cAMP-dependent protein kinase with [ Pj-y-ATP. 
Interestingly, the migration of these peptides was very similar to 
those reported by Mitchell and his colleagues (40 , 45) in their studies 
of phosphorylation of purified bovine glycogen synthase with two 
kinases. 
The physiological significance of multiple phosphorylation in the 
regulation of glycogen synthase is still poorly understood. Mitchell 
and Thomas (45) reported that cAMP-dependent protein kinase alone was 
capable of completely inactivating the bovine cardiac glycogen synthase 
by incorporating two phosphates into each subunit. The cAMP-independent 
protein kinase alone was also able to completely inactivate the enzyme 
by incorporation of one phosphate per subunit at a separate site. When 
both kinases were used simultaneously, all three phosphates in each 
subunit were required to fully inactivate the enzyme. These data sug­
gested that cooperativity between the phosphorylation sites may exist. 
Consequently, the multiple phosphorylation may provide multiple points 
of regulation of the glycogen synthase activity in cell. Moreover, 
because most kinases that are able to phosphorylate glycogen synthase 
have broad substrate-specificity, cooperativity among multiple phos­
phorylation sites may somehow provide some specificity for regulating 
glycogen synthase phosphorylation in vivo. 
14 
Dephosphorylation of Glycogen Synthase 
Since Friedman and Larner (18, 19) first demonstrated the dephos­
phorylation of glycogen synthase in skeletal muscle twenty years ago, 
the dephosphorylation reaction has been receiving a great deal of at­
tention. Despite these efforts, understanding of the dephosphorylation 
reaction has evolved very slowly. The enzyme (s) that catalyzed the de­
phosphorylation of glycogen synthase, glycogen synthase phosphatase(s), 
has been difficult to study because of the unstable nature of most 
preparations. 
Substrate specificity of glycogen synthase phosphatase(s) 
In 1972, Kato and Bishop (118) reported a procedure to partially 
purify the glycogen synthase phosphatase from rabbit skeletal muscle. 
Their purification scheme was similar to that reported previously by 
Villar-Palasi (119) except that a step in which the preparation was sub­
jected to freezing and thawing in the presence of Mn^  and mercapto-
athanol. They noted that s histone phosphatase activity was co-
purified with the glycogen synthase phosphatase, and that the histone 
phosphatase and the glycogen synthase phosphatase activities were in a 
constant ratio, implying that the two activities might be resided on 
the same protein. Zieve and Glinsmann (120) further investigated the 
32 
substrate specificity of the phosphatase using [ P]-release as an en­
zyme assay. Likewise, they noted that the ratio of phosphorylase kinase 
phosphatase activity to glycogen synthase phosphatase activity remained 
constant during the purification. In addition, they noted that only 
the active form (presumably the phosphorylated form) of phosphorylase 
15 
kinase was an effective competitive inhibitor of the glycogen synthase 
phosphatase. Nakai and Thomas (121) later attempted to separate the 
glycogen synthase phosphatase activity from other protein phosphatase 
activities which they isolated from bovine heart. The activities were 
not separable on DEAE-cellulose chromatography, molecular sieve 
chromatography, isoelectric focusing, and gel electrophoresis. The 
data of Kato and Bishop (118), Zieve and Glinsmann (120), and Nakai 
and Thomas (121), taken together, suggest that the several phosphatase 
activities in muscle cytosol may reside in a single protein species 
even though their preparations of glycogen synthase phosphatase were 
only partially purified. 
Antoniw et al. (122), on the other hand, reported the separation 
of three phosphoprotein phosphatase activities on Sephadex G-200 
column. Two of the phosphatases (the largest and the smallest) dis­
played a rather broad substrate specificity; whereas the other one ap­
parently was quite specific for a-subunit of phosphorylase kinase. 
The possible existence of a glycogen synthase specific phosphatase 
has been suggested in many in vivo studies. The studies of Tan and 
Nuttall (123, 124) demonstrated that hormonal and nutritional treatment 
altered glycogen synthase phosphatase activity with no apparent change 
in phosphorylase phosphatase activity. Villar-Palasi (119) suggested 
that glycogen synthase phosphatase and phosphorylase phosphatase isolated 
from skeletal muscle were probably different based on the fact that he 
could detect no competitive interactions between two substrates. Several 
groups (125, 126) have observed that hepatic synthase phosphatase is 
more labile than phosphorylase phosphatase. During the development of 
16 
rat liver, glycogen synthase phosphatase emerged at day 18 of gestation 
while phosphorylase phosphatase did not appear until day 21 (127). It 
was also reported that the glycogen synthase phosphatase activity was 
lost during the purification of phosphoprotein phosphatase from rat 
liver. Moreover, in contrast to the findings of Brandt et al. (128), 
Tan and Nuttall (124) noted that, while ethanol precipitation of crude 
liver extracts markedly activated phosphorylase phosphatase, the 
activity of synthase phosphatase was not appreciably changed (129). 
In fact, Kikuchi et al. (130) reported that the rat liver glycogen 
synthase phosphatase could be separated from the phosphorylase phos­
phatase on DEAE column chromatography. 
Molecular nature of glycogen synthase phosphatase 
It has been reported that glycogen synthase phosphatases could exist 
in multiple molecular forms. Kato and coworkers (131, 132) identified 
two phosphatase fractions from skeletal muscle with approximate molecular 
weights of 300,000 and 150,000. Each displayed activity towards phos­
phorylase a, histone, and glycogen synthase. Abe and Tsuiki (133) also 
identified and separated three species of glycogen synthase phosphatase 
activities on the basis of molecular size in the soluble fraction from 
liver. These glycogen synthase phosphatases, however, were resolved 
into not less than six activities by ion-exchange chromatography. 
Multiple forms of phosphoprotein phosphatases were also demonstrated in 
bovine heart (134), bovine adrenal cortex (135), liver (136) and skeletal 
muscle (137). 
In 1975, Brandt and coworkers (128) reported the purification and 
17 
characterization of a homogeneous phosphoprotein phosphatase from rabbit 
liver. The most crucial step in their procedure was a step involving 
ethanol precipitation at room temperature. The ethanol treatment 
activated the phosphatase activity and also dissociated the enzyme into 
monomeric species. The resulting preparation was homogeneous according 
to SDS-gel electrophoresis, with an apparent molecular weight of 34,000. 
They speculated that multiple forms of the enzyme observed by others 
were generated from a single high molecular weight species by partial 
proteolysis. When rat livers were extracted under conditions that 
minimized proteolysis, a single form of enzyme with an apparent molecular 
weight of 220,000 was reproducibly obtained (138). Indeed, they later 
successfully identified a heat-stable protein inhibitor that combined 
with the low molecular weight phosphatase from rabbit liver (139). 
Mellgren et al. (140) demonstrated that there was an endogeneous Ca^ -
dependent protease able to degrade the 260,000 daltons phosphorylase 
phosphatase to an active 70,000 daltons phosphatase. A second Ca^ -
dspendent protease further degraded the 70,000 daltons phosphatase to 
the active 35,000 daltons species. The substrate specificity of the 
low molecular weight phosphatase (M^  = 34,000) was also examined (141). 
They also noted that the substrate specificity was broad. 
Khandelwal et al. (142) also reported the purification of homogeneous 
phosphoprotein phosphatase from rabbit liver. In contrast to the results 
of Brandt et al. (128), they obtained two distinct homogeneous fractions 
of phosphoprotein phosphatases on hi s tone-Se pharose column, namely 
phosphatase I and II. Each fraction migrated as a single diffuse band 
with apparent molecular weights of 30,500 for I and 34,000 for II. 
18 
Li and his colleagues (143) discovered that a Mg^ -dependent alkaline 
phosphatase-like activity co-purified with the low molecular weight 
phosphoprotein phosphatase, which they isolated according to Brandt 
et al. (128) from canine heart. In light of this, Lee and coworkers 
(144) re-examined their preparation of low molecular weight phospha-
I I tase. A Mg -dependent alkaline phosphatase, which had low activity 
towards phosphorylase, was discovered; and could be separated from the 
low molecular weight phosphatase at least in the rabbit muscle system. 
Nevertheless, this low molecular weight phosphatase, unlike the partially 
purified phosphatases used by Kato and Bishop (118), Nakai and Thomas 
(121), and Zieve and Glinsmann (120), was not affected by divalent 
cations, but yet had a very broad substrate specificity. 
Dopere et al. (145) recently reported that the glycogen synthase 
phosphatase in rat liver was composed of two different protein components. 
The G-component, which co-sedimented with particulate glycogen, was 
not active by itself. The phosphatase activity of the S-component, which 
was not co-sedimented with glycogen, depended on the actual type of 
phosphorylated glycogen synthase. The full glycogen synthase phospha­
tase activity required the presence of both components. In addition, 
they also reported the isolation of three different fractions of phos­
phorylated glycogen synthase from canine liver on the basis of different 
affinity for DEAE-cellulose. The suitability of these phosphorylated 
glycogen synthases as substrate for the dephosphorylation reaction by 
their synthase phosphatase was quite different, implying that phos­
phorylated glycogen synthase molecules in vivo may ezist in different 
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forms; and that the substrate may play a major role in the regulation of 
glycogen synthase dephosphorylation reaction vivo. 
Alkaline phosphatases as phosphoprotein phosphatases 
Because the nature of glycogen synthase phosphatases has not been 
established, studies of glycogen synthase dephosphorylation have been in­
conclusive, Mellgren and Thomas (146) suggested the possibility of using 
E. coli alkaline phosphatase^  to study the glycogen synthase dephosphoryla­
tion reaction. They demonstrated that the bacterial alkaline phospha­
tase was able to completely convert the purified phosphorylated bovine 
cardiac glycogen synthase to the active (dephosphorylated) form. The 
enzyme conversion was shown to be the result of dephosphorylation. 
They demonstrated that the effectors of the reaction probably affected 
dephosphorylation of glycogen synthase by substrated-mediated mechanisms 
(147). Human placental (148) and calf intestinal (149) alkaline phos­
phatases have also been used to study the dephosphorylation of glycogen 
synthase. Unlike E. coli alkaline phosphatase, the human placental 
alkaline phosphatase only dephosphorylated one of the two phosphates on 
each glycogen synthase subunit leading to a partial reactivation of 
the enzyme (150). Similarly, calf intestinal alkaline phosphatase was 
only able to remove three out of four phosphates from each subunit of 
another phosphorylated enzyme (149). This dephosphorylation reaction 
did not result in an increase in the activity ratio of the enzyme. 
The alkaline phosphatases have proven to be useful tools for studying 
dephosphorylation of glycogen synthase. 
O^rthophosphoric monoester phosphohydrolase, EC 3.1.3.1. 
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Effectors of glycogen synthase phosphatase 
Many ions have effects on the glycogen synthase phosphatase reac­
tions. Fluoride, inorganic phosphate, and pyrophosphate are known to 
be potent inhibitors for the dephosphorylation reaction (121). Kato 
and Bishop (118) discovered that their preparation of partially purified 
glycogen synthase phosphatase from skeletal muscle was stimulated by 
Mn , Ca , and Mg . The same enzyme was later studied by Kato and 
Sato (131), and the phosphatase activity was separated into two peaks 
on Sephadex G-150. The higher molecular weight species was not in­
fluenced by divalent cations, but the low molecular weight species was 
totally dependent on Mn or Ca for activity. Nakai and Thomas (121) 
also reported that Mg^ , Ca"^ , and Mn^  stimulated phosphatase from 
bovine heart when the substrates were phosphohistone or glycogen 
synthase D, but inhibited the reaction when phosphorylase a was the 
substrate. On the other hand, Killilea et al. (141) found that 10 mM 
Mg"*^  inhibited the dephosphorylation of purified glycogen synthase D 
•when they used their preparation of homogeneous low molecular weight 
phosphatase from liver. Recently, Khandelwal (151) examined the in­
fluences of divalent cations on the homogeneous hepatic low molecular 
weight phosphatases. Dephosphorylation of purified glycogen synthase 
was not influenced by or Ca , and the dephosphorylation of his-
tone was not affected by Mg'". With these exceptions, the activity of 
his phosphatase was inhibited by all cations tested with glycogen 
synthase D, phosphorylase a, and phosphohistone as substrates. The 
findings of Nakai and Thomas (121) and Khandelwal (151) together 
implied that substrates may also play a role in the regulation of 
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phosphatase activity by divalent cations. The role of divalent cations 
in the regulation of the dephosphorylation reaction, however, is still 
obscure because (i) the role of the metal in enzyme stability versus 
the enzyme activity of various enzyme forms has not been resolved, 
(ii) the state of purity and molecular heterogeneity of various enzyme 
and substrates have made comparison among studies very difficult, and 
(iii) different molecular forms may vary in sensitivity to the cations. 
Inhibitory effects of ATP on glycogen synthase phosphatase activity 
have been observed (133, 152-154). Gilboe and Nuttall (155, 156) re­
vealed that ATP at physiological concentrations markedly inhibited 
glycogen synthase dephosphorylation. This inhibition was reversed by 
glucose in the case of liver enzyme and by glucose-6-P with the muscle 
preparation. They speculated that an increase in hexose or hexose 
phosphate level increased the glycogen synthase phosphatase reaction 
rate by decreasing ATP inhibition. The physiological significance of 
such a regulatory mechanism is questionable since most cellular ATP 
exists as Mg'^ -ATP complex, and also since Merlevede et al. (126) 
demonstrated that the Mg'^ -ATP complex stimulated phosphoprotein phos­
phatase activities in many tissues. Nakai and Thomas (121) found that 
all the nucleotides tested except cAMP had inhibitory effect on both 
glycogen synthase phosphtase and phosphorylase phosphatase activities, 
but not on the histone phosphatase activity. A similar study was re­
peated with a homogeneous preparation of liver phosphatase and highly 
purified protein substrates by Khandelwal (151). ATP and ADP were 
more inhibitory toward glycogen synthase dephosphorylation than 
phosphorylase dephosphorylation, while AMP was a much more potent 
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inhibitor of phosphorylase phosphatase activity. The uridine nucleo­
tides were not effective inhibitors, and UDP-glucose did not inhibit 
any of the dephosphorylation reactions. 
The effects of glucose and glucose-6-P on the dephosphorylation of 
glycogen synthase have also been investigated. Glinsmann et al, (157) 
clearly demonstrated that glucose can promote the activation of glycogen 
synthase and inactivation of phosphorylase in isolated perfused 
liver without affecting the level of cAMP. Hers (158) observed 
that inactivation of phosphorylase preceded the activation of 
glycogen synthase phosphatase activity. They speculated that glucose 
first binds to phosphorylase a, making it a "better" substrate for the 
phosphorylase phosphatase and thus facilitating the conversion of phos­
phorylase a to b. Once phosphorylase a was decreased below a critical 
threshold, the inhibition of glycogen synthase phosphatase would be re­
lieved and the conversion of glycogen synthase D to I could then pro­
ceed. There have been no reports of direct influence of glucose on the 
glycogen synthase dephosphorylation reaction. Glucose-6-? has been 
shown to stimulate glycogen synthase phosphatase from many tissues 
including spleen (159), heart (121), human leucocytes (160), adipocytes 
(161), liver (141) and skeletal muscle (118). Although the mechanism 
of glucose-6-P action on the phosphatase reaction is still unclear, 
the data of Kato and Bishop (118) and Nakai and Thomas (121) suggested 
that its effects are primarily on the substrate, glycogen synthase. 
Because glycogen synthase forms a very tight complex with glycogen, 
glycogen might significantly influence the activity of glycogen synthase 
phosphorylation or dephosphorylation. A good correlation between the 
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glycogen content in tissues and the phosphorylation state of glycogen 
synthase in skeletal muscle (162), diaphragm (162), heart (163) 
and liver (164) has been shown. It is now clear that glycogen is a 
significant inhibitor of many glycogen synthase dephosphorylation 
reactions (118, 119, 165). The effect of glycogen on glycogen synthase 
dephosphorylation apparently is a substrate-directed event because 
glycogen has no inhibitory effect on the dephosphorylation of phosphory-
lase a (166) nor on his tone dephosphorylation (118). Glycogen did not 
affect the hydrolysis of p-nitrophenyl phosphate by E. coli alkaline 
phosphatase, T^ ereas it inhibited the dephosphorylation of glycogen 
synthase catalyzed by the same enzyme (147). 
Heat stable phosphatase inhibitory proteins 
The discovery of heat stable phosphatase inhibitory proteins has 
augmented our understanding of regulation of the glycogen synthase de­
phosphorylation reaction. The initial observation of such inhibitory 
proteins was made by Baba and Tsuiki (167). They were able to identify 
a heat stable, nondialyzable glycogen synthase phosphatase inhibitory 
protein which had no effect on the phosphorylase phosphatase activity. 
Shortly afterward, Brandt et al. (138) independently described a protein 
inhibitor of phosphoprotein phosphatase present in extracts derived from 
liver, skeletal muscle and heart. The inhibitor could be destroyed by 
either ethanol or trypsin treatments. This inhibitor, unlike the one 
described by Baba and Tsuiki (167) inhibited both glycogen synthase 
phosphatase and phosphorylase phosphatase activities. Huang and Glins-
mann (168) later found that there was another phosphatase inhibitor 
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that was active only when it was phosphorylated by cAMP-dependent protein 
kinase. This inhibitor was rather specific for the phosphorylase de-
phosphorylation reaction. Huang and Glinsmann (169, 170) soon confirmed 
the presence of two protein inhibitors of phosphatase. The first 
inhibitor, termed inhibitor-l, corresponded to the previously described 
phospho-inhibitor and the second inhibitor, denoted inhibitor-2, was 
not phosphorylated and was as effective as inhibitor-l in noncompetitively 
inhibiting phosphatase activity. Inhibitor-2, unlike inhibitor-l, 
inhibited the glycogen synthase phosphatase activity. Because inhibitor-l 
was phosphorylated to be active, it was a potential candidate for 
hormonal effects on phosphatase activity in vivo. Both inhibitors have 
been purified to homogeneity and have been studied extensively by many 
groups (88, 90, 171-181). There is no strong evidence for the physio­
logical function of these inhibitors, although evidence have been ob­
tained that inhibitor-l undergoes phosphorylation in vivo in muscle in 
response to adrenaline (181), and dephosphorylation ^  vivo in response 
to insulin (178). On the other hand, the native protein phosphatases 
may be unaffected by these inhibitors, as suggested by the studies of 
Goris et al. (182). Laloux and Hers (183) presented data to suggest 
that the appearance of heat-stable inhibitors in muscle extracts was 
time-dependent and suggested that the process of generating inhibitors 
was the result of post-homogenization event, and thus, was irrelevant 
to the in vivo situation. 
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Hormonal Regulation of Glycogen Synthase Activity 
Interconversion of the phospho- and dephospho-glycogen synthase 
is subjected to hormonal regulation. While the biochemical events as­
sociated with the activation of the kinases by hormones have been ex­
tensively studied and are fairly well-understood (32, 88-90), only 
recently has firm evidence accumulated indicating hormonal control of 
the dephosphorylation reaction. 
Insulin 
Insulin has been known for several years to promote the activation 
of glycogen synthase in many tissues both in vivo and in vitro (163, 
168, 184, 185). The mechanism is as yet unclear, but it could result 
from inhibition of protein kinase activity, activation of the dephos-
phorylation reaction, or a combination of both. Villar-Palasi et al. 
(81) demonstrated that insulin administration converted the cAMP-
dependent protein kinase from its active catalytic subunit to its in­
active holoenzyme in skeletal muscle. The similar effect of insulin 
was subsequently reported in liver (186) and in rat diaphragm (187-
190). Insulin alone, however, did not affect the cellular concentra­
tions of cAMP in many tissues (10, 186, 190-192). Recently, Walkenbaeh 
et al. (193) reported that insulin treatment of rat diaphragms decreased 
binding of [ Hj-cAH? to cAMP-dependent protein kinase holoenzyme, and 
induced a reversible inhibition of cAMP stimulation of protein kinase 
activity. They proposed that insulin generated a labile inhibitor 
acting directly on the protein kinase holoenzyme to prevent cAMP activa­
tion. Oron and his coworkers in Larner's laboratory (194) recently also 
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demonstrated that insulin inhibited endogeneous protein phosphorylation 
in mouse diaphragm. In addition, Larner and his coworkers (195) identi­
fied a peptide-like mediator substance generated by insulin treatment 
from skeletal muscle, xdiich inhibited cAMP-dependent protein kinase and 
also stimulated glycogen synthase phosphatase activity. At the same 
time, Jarett and Seals (196) demonstrated that a fraction from insulin-
treated skeletal muscle stimulated pyruvate dehydrogenase activity in 
adipocyte mitochondria. It is not clear if the factors identified by 
these two laboratories are the same. Recently, Walkenbach et al. (197) 
reported that insulin antagonized epinephrine's effect in rat hemidia-
phragms. Insulin had no effect on cAMP produced by varying levels of 
epinephrine, but the activation of protein kinase activity by endogeneous 
cAMP was inhibited. It was speculated that the effect of insulin on 
epinephrine action was to decrease the sensitivity of cAMP'-dependent 
protein kinase holoenzyme to cAMP. A similar inhibition by insulin of 
glucagon-stimulated protein kinase activity in rat renal cortical slices 
with no change in cAMP has also been reported (198). However, Skikama 
et al. (199) recently examined the inhibitory effect of insulin on 
epinephrine action on muscle glycogen metabolism with an isolated per­
fused rat hindlimb preparation. They observed that with insulin (10 
to 10 ^  M) and epinephrine (10 ^  to 10 ^  M) perfused together, insulin 
had no inhibitory effect on the action of epinephrine on glycogen syn­
thase, phosphorylase or cAMP-dependent protein kinase. Consequently, 
their data contradicted the idea that insulin activates glycogen syn­
thase by producing an inhibitor of protein kinase as proposed by Larner 
and his coworkers. 
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Insulin has been demonstrated to significantly influence the activity 
of glycogen synthase phosphatases. Gold (200) and Bishop (201) were 
amnng the first to present evidence for the involvement of phosphatase 
in the action of insulin. Gold (200) observed that alloxan-induced 
diabetes in rats resulted in a loss of hepatic glycogen synthase phos­
phatase activity. Insulin treatment of diabetic animals led to complete 
restoration of the hepatic synthase phosphatase activity. Since the 
phosphatase activity in his study was assessed by measuring the conversion 
of endogeneous glycogen synthase, it was not possible to attribute the 
effects of the diabetes and insulin to the substrate, to the level of 
phosphatase, or to some other indirect effectors. Bishop (201) examined 
the hepatic phosphatase activity of pancreatectomized dogs maintained 
on variable amounts of insulin using purified glycogen synthase D as 
substrate. Insulin promoted a two- to four-fold increase in glycogen 
synthase phosphatase activity. The addition of glucagon to the insulin-
plus-glucose infusion brought the phosphatase activity back to or below 
control levels. The diabetic animals without daily insulin injections 
for two to four days did not respond to a single insulin injection. 
Tan and Nuttall (124) also examined glycogen synthase phosphatase 
and phosphory1ase phosphatase activities in liver extracts of alloxan-
diabetic rats using both endogeneous and purified exogeneous substrates. 
Using endogeneous substrate, they found that phospho- to dephospho-
glycogen synthase conversion in liver extracts varied with nutritional 
states. Extracts derived from diabetic-fed rats showed markedly de­
creased glycogen synthase phosphatase activity. Endogeneous hepatic 
glycogen synthase conversion in diabetic-fasted rats was rapid and 
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complete. Using exogeneous substrate, 24 br-fasted normal rats demon­
strated significantly reduced hepatic synthase and phosphorylase phospha­
tase activities. In fed state, both phosphatase activities were de­
creased in diabetic rats when compared to nondiabetic animals. No dif­
ference in both phosphatase activities were detected in these two groups 
of animals when they were fasted for 24 hr. The glycogen synthase 
phosphatase activity in the alloxan-diabetic rats was increased to only 
50% of the controls with insulin. 
Khandelwal et al. (202) studied the effect of streptozotocin-
induced diabetes and insulin treatment on phosphatase activities in 
rat liver using (a) endogeneous phospho- to dephospho-glycogen synthase 
and phosphorylase a to b conversions, (b) dephosphorylation of exogeneous 
32 [ P]-labelled phosphorylase, and (c) histone dephosphorylation. The 
hepatic phosphatase activity was diminished in the diabetic animals 
with all substrates. They also measured the activity of a heat-stable 
protein inhibitor of phosphoprotein phosphatase in extracts of normal 
and diabetic rat liver. Inhibitor activities were markedly increased 
in diabetic rat liver. Recently, it has also been reported that insulin 
decreased the phosphorylation and activity of a heat-stable protein 
protein inhibitor of a general phosphoprotein phosphatase in muscle 
(178). It was suggested that insulin may act by decreasing the activity 
of an inhibitor of the phosphoprotein phosphatase (178, 202), Khatra 
and coworkers (203) were unable to confirm the suggested effect of in­
sulin on the phosphoprotein phosphatase inhibitor. 
Khandelwal et al. (204) investigated the effects of diabetes and 
insulin on glycogen metabolism in rat kidney. As in heart (205), the 
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renal glycogen content was higher in diabetic animals than in control 
or insulin-treated diabetic animals. The glycogen synthase I level in 
diabetic animals was markedly decreased and it could be reversed by 
insulin treatment. The glucose-6-P level in diabetic animals, however, 
was significantly higher than that in the other two groups, They 
speculated that accumulation of renal glycogen in diabetic animals is 
due to the increased amount of the glucose-6-P. 
Lawrence and Larner (161) reported that insulin and other agents 
which activate hexose transport were able to promote activiation of 
glycogen synthase by activating glycogen synthase phosphatase in isolated 
adipocytes. They also presented evidence for two mechanisms in which 
insulin stimulates glycogen synthase D to I conversion in these cells. 
First, insulin acts directly to activate the glycogen synthase, and 
secondly, the insulin effect was dependent upon sugar transport. They 
reported that insulin, in the absence of glucose, stimulated a signifi­
cant dephosphorylation (%I form of the enzyme from 9.2% to 15.3%) 
but in the presence of sugar, the increase was much larger (97» to 30%). 
Glucose alone was ineffective. Insulin alone had little effect on 
glucose-6-P concentration in these cells, while insulin-plus-glucose 
produced a 10-fold increase in the effector concentration. Because it 
has been shown that glucose-6-P stimulated glycogen synthase phospha­
tase in vitM (118, 121, 141, 159-161), insulin-induced alterations in 
the cellular level of glucose-6-P could play an important role in the 
intracellular effects of the hormone on glycogen synthesis through the 
activation of glycogen synthase phosphatase. 
Miller (206) studied the effect of insulin on regulation of glycogen 
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synthase activity in perfused rat hearts. He reported that insulin led 
to a two-fold increase in the activity of glycogen synthase I form in 
the normal fed rat hearts. The glycogen synthase activity in fed alloxan-
diabetic rat hearts was unresponsive to insulin perfusion. Neither in­
sulin or diabetes had any effect on the activity of phosphorylase or 
protein kinase, or on the tissue concentrations of cAMP. Total glycogen 
synthase phosphatase activity in diabetic hearts was decreased 60 to 
70%. The restoration of glycogen synthase dephosphorylation (glycogen 
synthase phosphatase activity) could be achieved by administration of 
insulin to the diabetic rats 1 to 6 hr prior to heart perfusion. This 
restoration could be blocked by simultaneous injection of cycloheximide. 
Accordingly, Miller proposed a dual role for insulin in the regulation 
of cardiac glycogen synthase in which one effect involves protein synthesis 
and maintenance of the enzymatic machinery responsible for acute regula­
tion of glycogen synthase activity, and the other effect is a rapid 
effector activation of glycogen synthase through an unknown mechanism. 
Insulin action on glycogen synthase dephosphorylation in liver has 
also been examined. Miller (207) reported that cycloheximide blocked 
insulin effects on the restoration of glucose regulation of hepatic 
glycogen synthase in diabetic rats. Haverstick et al. (208) also ob­
served that the insulin-induced hepatic phosphorylated to dephosphory-
iated glycogen synthase conversion was blocked by cycloheximide. These 
data suggested that the insulin control of glycogen synthase activity 
in liver is dependent upon eye1oheximide-s ens i tive protein synthesis. 
A significant contribution in this area was made by Nuttall and 
coworkers (209). They reported that the synthase phosphatase activities. 
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measured in concentrated extracts in normal-fasted and alloxan-diabetic 
rat hearts were about half of that of the hearts of the normal fed rats. 
Insulin stimulated the synthase phosphatase activity in both nondiabetic-
f as ted and diabetic, but not the normal fed rat hearts. The insulin 
effect on the synthase phosphatase activity was not apparently due to 
some low molecular weight effectors (i.e., glucose-6-P). The insulin 
effect was still present after Sephadex G-25 chromatography and ammonium 
sulfate precipitation of the heart extracts, suggesting that insulin may 
induce a stable modification of the phosphatase itself or its substrate 
rendering the latter a more favorable substrate for the reaction. _ They 
also reported that dephosphorylation of glycogen synthase in fed rat 
hearts was less sensitive to glycogen inhibition than that in fasted 
hearts. Insulin administration reduced the sensitivity of the reaction 
to glycogen inhibition. The observed difference in the sensitivity of 
the reaction to glycogen inhibition may be attributed to a difference in 
the glycogen synthase phosphatase, in the glycogen synthase, or in both, 
because the ratio of the phosphatase to glycogen synthase in their reac­
tions was limited by the contents in the extracts. Since the inhibitory 
effect of glycogen on the dephosphorylation is very likely to be 
substrate-mediated (118, 147, 166), the action of insulin on the glycogen 
synthase dephosphorylation reaction may also be through the effect on 
the substrate. 
Other hormones 
Adrenal glucocorticoids have long been known to be activators of 
hepatic glycogen synthase (210). Evidence has accumulated to Indicate 
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that the effect was mediated through activation of the hepatic phospho-
protein phosphatases (211, 212). Nichols and Goldberg (213) revealed 
that the glycogen synthase phosphatase activity was not changed by 
steroid administration in adrenalectomized alloxan-diabetic rats. 
Insulin administration to the diabetic-adrenalectomized rats fasted 
12 hr produced marked increases in both the glycogen synthase activity 
and the glycogen synthase phosphatase activity of these livers. They 
concluded that the apparent steroid activation of glycogen synthase 
and synthase phosphatase in vivo was dependent on the release of insulin. 
Tan and Nuttall (124) have also shown that glycogen synthase D present 
in the liver of the adrenalectomized fasted rat was not converted to 
glycogen synthase I by glycogen synthase phosphatase from normal 
animals, suggesting the presence of a nonsubstrate form of glycogen 
synthase D. 
The effects of EDTA on glycogen synthase dephosphorylation have also 
been examined. Gilboe and Nuttall (214) showed that approximately half 
of the glycogen synthase phosphatase activity in a glycogen pellet 
preparation from normal fed rats was inhibited by high concentrations 
of EDTA, Glucagon or cAMP administration markedly and rapidly increased 
the proportion of synthase phosphatase activity inhibitable by EDTA.. 
Epinephrine administration, however, had no effect. Glucose administra­
tion reduced the proportion of synthase phosphatase activity sensitive 
to EDTA inhibition while insulin administration had no effect. They 
suggested that either synthase phosphatase or its substrate, glycogen 
synthase D, may exist as rapidly interconvertible forms detectable by 
a change in EDTA inhibitability. LaLoux and Hers (215) recently have 
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suggested that the inhibitory effect of EDT&. is transient and is due to 
phosphorylase a in the incubation mixture. In light of this, Nuttall 
and Gilboe (216) more recently re-examined the effect of EDTA on the 
synthase phosphatase activity in liver. They indeed observed a cor­
relation of the change in phosphorylase ^  concentration with the 
synthase phosphatase activity in glycogen pellet in the presence of 
EDTA. They did not, however, detect any threshold release of phospha­
tase activity when phosphorylase a reached a critical level. They 
concluded that either an independent regulation of glycogen synthase 
phosphatase by glucose and glucagon, or regulation of the phosphatase 
activity by phosphorylase over a range of phosphorylase a concentration 
is involved. 
It is now clear that a multiplicity of factors interact cooperatively 
or antagonistically to regulate the activities of glycogen synthase and 
the interconversion enzymes. While there has been considerable and 
dramatic progress made in the past several years, it is quite clear that 
the surface has only just been scratched, and that further investigation 
of the kinases, phosphatases, and glycogen synthase, and their individual 
roles in mediating the intracellular effects of hormone and other 
metabolic effectors are needed. 
In this dissertation, evidence is presented to show that sensitivity 
of dephosphorylation of purified cardiac glycogen synthase to glycogen 
inhibition was changed by altering the oxidation state of one or more 
protein sulfhydryls in the enzyme. Treatment of glycogen-free glycogen 
synthase with oxidized glutathione converted the enzyme from a state 
in which its dephosphorylation was very sensitive to glycogen inhibition 
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to a state in xAich the dephosphorylation required a relatively large 
amount of glycogen to produce a significant inhibition. In addition to 
the alteration in glycogen sensitivity of the dephosphorylation, reaction 
of glycogen-free cardiac glycogen synthase I with low molecular weight 
disulfides resulted in reversible enzyme inactivation. The effects of 
low molecular weight disulfides on glycogen synthase were through the 
formation of protein mixed-disulfides, Evidence is also presented to 
demonstrate that E. coli alkaline phosphatase could be used to study 
the regulation of glycogen synthase dephosphorylation in rat heart ex­
tracts. Glycogen synthase dephosphorylation in rat hearts responded 
differently to glycogen inhibition depending on the nutritional state 
of the animal. 
Explanation of Dissertation Format 
This dissertation follows an alternate format in which there are 
three sections after the General Introduction. The first section has 
been published, the second section will be submitted for publication, 
and the third section has been accepted for publication. 
In the first section, all experiments except Figure I-l were 
performed by the author with helpful discussion from Dr. James A. 
Thomas. Figure I-l was obtained from the Ph.D. dissertation of Dr. 
Ronald L. Mellgren. The manuscript was organized by the author with 
suggestions from Dr. Thomas, and the final copy was revised by Dr. 
Thomas. It has been published in Cold Spring Harbor Conferences on 
Cell Proliferation, Volume 8: Protein Phosphorylation. 
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All experiments in the second section were performed by the author 
with helpful advice and discussion from Dr. Thomas. The section was 
prepared by the author and is presented in a format for submission to the 
Journal of Biological Chemistry. 
The third section is a manuscript submitted and accepted for publica­
tion in Molecular and Cellular Biochemistry. I-I Grace Chen contributed 
the experiment in Figure III-7. All other experiments were performed 
by the author. The first draft of the manuscript was organized and 
written by the author. The final form of the manuscript was revised 
by Dr. Thomas. 
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SECTION I: COVALENT MODIFICATION AND REGULATION OF BOVINE CARDIAC 
GLYCOGEN SYNTHASE; POSSIBLE REGULATION OF THE 
PHOSPHORYLATION STATE THROUGH SULFHYDRYL MODIFICATION 
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Introduction 
Research over the last twenty years has clearly demonstrated that 
mammalian glycogen synthases are regulated by phosphorylation-dephos-
phorylation of serine residues in the enzyme. Heart glycogen synthase 
is no exception to this statement (1) and it has even been possible to 
demonstrate the phosphorylation of this enzyme in intact heart tissue 
(2). Recently, interest has centered on the role of several different 
phosphorylation sites on each glycogen synthase subunit, and on the 
phosphorylation of glycogen synthase by several protein kinases. Heart 
glycogen synthase is a multiply phosphorylated enzyme (3) and acts as 
the substrate for more than one protein kinase (4). 
Since glycogen synthase forms a tight complex with glycogen, and 
since glycogen seems to be required as a primer in the reaction catalyzed 
by this enzyme, several groups have studied the effects of glycogen on 
glycogen synthase. It has been shown that the amount of glycogen re­
quired as a primer for the reaction is very low (5) and that structural 
requirements of the polysaccharide for this function are quite stringent 
(6). In the case of the glycogen synthase from liver, it has also been 
shown that glycogen binding was affected by the oxidation state of the 
enzyme sulfhydryl groups (7, 8). Experiments with intact skeletal muscle 
(9) and heart (10) have also shown that phosphorylation state of glycogen 
synthase in these tissues may be directly related to the glycogen con­
tent. This phenomenon was related to glycogen inhibition of glycogen 
synthase dephosphorylation (11). Since glycogen synthase, as well as 
other enzymes of glycogen metabolism, may exist in a multi-molecular 
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structure in complex with glycogen in vivo (12), the phosphorylation 
state of glycogen synthase might be related to some properties of the 
association or binding to glycogen. 
The experiments reported here are an attempt to determine the ef­
fects of glycogen on the dephosphorylation of heart glycogen synthase 
using the dephosphorylation reaction catalyzed by E. coli alkaline 
phosphatase (13) as a model system. 
Materials and Methods 
E. coli alkaline phosphatase was purchased from Worthington Bio­
chemical Corp. (BAPF alkaline phosphatase). The enzyme was centrifuged 
and redissolved in 50 mM Tris, pH 7.8 at approximately 100 units/ml 
before use. Rabbit liver glycogen was purchased from Sigma Chemicals 
(type III) and was treated with Amberlite MB-3 resin before use. All 
glycogen solutions were analyzed by the phenolsulfuric acid method (14) 
with glucose as the standard. 
Bovine heart glycogen synthase was purified by methods recently 
described (3). After phosphorylation with a mixture of cAMP-dependent 
and independent protein kinases, the enzyme was made glycogen-free by 
incubating the enzyme with 20 mM dithiothreitol, 25% glycerol, and 
10 M-g/ml salivary a-amylase (30°, 45 min). The enzyme was applied to 
a DEAE-Sephacel column (1 ml resin/ml enzyme) and the column was washed 
with ten volumes of 50 mM Tris-HCl, 5 mM dithiothreitol, and 25% 
glycerol at pH 7.5. Glycogen synthase was eluted with the same buffer 
containing 0.5 M NaCl and active fractions were dialyzed against 50 mM 
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Tris-HCl, 50 mM KF, and 50% glycerol at 4° for three hours and then over­
night at -20°. The enzyme was stored at -20°. 
Glycogen synthase was assayed by the method of Thomas et al. (15). 
Percent glycogen synthase I (% GSI) was determined by assays with 14 mM 
Na^ SO^  for glycogen synthase I and with 10 mM glucose-6-P for total 
glycogen synthase. UDP-glucose had a specific activity of 40,000 
cpm/ lanol. 
Glycogen synthase was dephosphorylated by either a phosphoprotein 
phosphatase or E. coli alkaline phosphatase at 30° in reaction mixtures 
containing glycogen synthase (0.5 units/ml), 50 mM Tris-HCl, 100 mM KF, pH 
7.8, 100 mM 25% glycerol. Aliquots of the phosphatase reaction 
mixture were diluted seven-fold with cold buffer containing 50 mM Tris-HCl, 
5 mM dithiothreitol, 5 mM ED TA., 50 mM KF, and 1 mg/ml rabbit liver glyco­
gen, pH 7.8. Percent glycogen synthase I was determined on the diluted 
enzyme fractions. 
Results 
Studies on dephosphorvlation of purified heart glycogen synthase 
Previous results from our laboratory have shown that dephosphoryla-
tion of phosphorylated glycogen synthase can be catalyzed by E. coli 
alkaline phosphatase (13). Further, this reaction was regulated by many 
of the same substances that had effects on the rate of heart protein 
phosphatase-catalyzed glycogen synthase dephosphorylation. Glycogen 
inhibited the phosphatase reaction catalyzed by either heart protein 
phosphatase or the E. coli alkaline phosphatase, and the curves for 
glycogen dependence of the inhibition were nearly superimposable. Since 
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glycogen had no effect on p-nitrophenyl phosphate hydrolysis by the 
alkaline phosphatase, it was not likely that glycogen inhibition of 
glycogen synthase dephosphorylation occurred through direct effects on 
the phosphatase. These results suggested that glycogen inhibition of 
glycogen synthase dephosphorylation was mediated through interactions 
between glycogen synthase and glycogen. 
In further studies on the effects of glycogen, we have used a more 
highly purified preparation of glycogen synthase for the substrate. This 
glycogen synthase preparation contained a single major protein (analyzed 
by SDS-PAGE), and it was phosphorylated by a combination of cAMP-
dependent and -independent protein kinases. When this enzyme was used 
as a substrate for glycogen inhibition studies, the data shown in 
Figure I-l were obtained. The dephosphorylation reaction was maximally 
inhibited by less than 50 |Jg/ml glycogen when either phosphatase 
catalyzed the reaction. Since the results cited above (13) showed that 
maximum inhibition occurred with 8 to 10 mg/ml glycogen with a less 
pure glycogen synthase preparation, glycogen inhibition was apparently 
altered significantly with more purified preparations of glycogen syn­
thase. Maximum inhibition was very similar in all experiments, i.e., 
50-70%. 
Glycogen inhibition of the dephosphorylation of a single prepara­
tion of glycogen synthase also changed as the enzyme preparation aged. 
Highly purified glycogen synthase, with glycogen removed by a-amylase 
treatment, was stored at -20° in the absence of a reducing agent such 
as dithiothreitol or mercaptoethanol. Figure 1-2 shows that much more 
glycogen was required to inhibit dephosphorylation of this enzyme after 
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aging. The glycogen synthase changed from a substrate inhibited by 
low concentrations of glycogen, as shown in Figure I-l, to one that was 
inhibited only at glycogen concentrations approximating those normally 
found in heart tissue, i.e., 2 to 8 mg/ml. The inhibition curve also 
looked much like those obtained with less purified glycogen synthase. 
When aged enzyme was incubated with a reducing agent overnight at -20°, 
the enzyme preparation again became sensitive to low concentrations of 
glycogen. These data gave an indication that sulfhydryl groups on 
glycogen synthase were important in binding glycogen in an inhibitory 
complex that prevented rapid dephosphorylation of serine phosphate resi­
dues in the enzyme. Other properties of the dephosphorylation reaction 
were also affected by the oxidation state of the glycogen synthase. 
Kinetic plots obtained by varying the amount of glycogen synthase in 
the reaction (Figure 1-3) showed that the for the dephosphorylation 
was reduced after aging the enzyme. The for the original enzyme 
preparation was 1.8 units/ml glycogen synthase D, while that for the 
aged enzyme was 0.7 units/ml and for the reduced enzyme, it was 1.5 
units/ml. The observed values are very similar to those determined 
with partially purified heart protein phosphatase preparations. There 
was no change in the apparent maximum rate of dephosphorylation of these 
enzymes, but it was not possible to increase glycogen synthase concentra­
tion much above the or the substrate became inhibitory to the reac­
tion. 
Recently, it has been proposed that the oxidized form of glutathione 
(GSSG) is important in modification of protein sulfhydryls in vivo (16-
18). Therefore, GSSG effects on heart glycogen synthase were studied. 
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Figure 1-4 shows that GSSG is an inhibitor of the activity of heart 
glycogen synthase, an indication that sulfhydryl groups in glycogen 
synthase are reactive with this substance. The inhibition shown was 
dependent on the concentration of GSSG, and the time of incubation. 
At any given concentration of GSSG, the inactivation continued over 
several days under the incubation conditions employed (-20°), but it 
could be readily reversed by a short incubation of 5 to 10 minutes in 
the presence of 20 mM dithiothreitol. GSSG was without effect on glycogen 
synthase activity when the incubation was done at room temperature. 
Since the pH of the incubation (using Tris buffer) increased with de­
creasing temperature (8.1 at room temperature, 8.8 at -20°), these re­
sults suggest a reaction with a protein sulfhydryl group in glycogen 
synthase that is favored at higher pH. The incubation in Figure 1-4 also 
did not occur if the glycogen synthase first incubated with glycogen to 
form a glycogen-glycogen synthase complex. Therefore, the sulfhydryl 
groups involved in the reaction may also be involved in the binding 
glycogen to glycogen synthase. 
The effect of GSSG treatment on glycogen inhibition of the dephos­
phorylation of glycogen synthase is shown in Figure 1-5. A purified 
preparation of glycogen-free glycogen synthase was treated with 100 pM 
GSSG at -20° for 8 weeks. At that time, the enzyme had approximately 35% 
of its original activity unless it was incubated with 20 mM DTT. After 
incubation with DTT, the enzyme could be completely reactivated. The 
data in the figure show that dephosphorylation of the enzyme was inhibited 
only by glycogen concentrations in the range of 2 to 10 mg/ml. Enzyme 
that was stored with dithiothreitol showed no change in the glycogen 
44 
inhibition curve. The enzyme used for substrates in this experiment 
were passed through Sephacryl columns before being used for the 
phosphatase reaction in order to remove low molecular weight materials 
like GSSG or dithiothreitol. The reactivity changes shown must, there­
fore, be a result of stable changes in glycogen synthase. 
In further experiments with GSSG at higher concentrations (2 mM), 
the modification of the glycogen inhibition curve shown occurred in 11 
days. These data are shown in Figure 1-5 and correspond to the glycogen 
inhibition curve that was produced by treatment with 100 p.M GSSG for 
8 weeks. The enzyme was inactivated to 32% of its original activity. 
The enzyme was subsequently treated with dithiothreitol for 20 minutes 
at room temperature and the glycogen inhibition curve and glycogen 
synthase activity both returned to normal. 
Studies on dephosphorylation of glycogen synthase in heart extracts 
In order to determine if the glycogen synthase in crude extracts 
from rat heart might show a variable response to glycogen inhibition of 
the dephosphorylation reaction, we examined the possibility of studying 
dephosphorylation in extracts with E. coli alkaline phosphatase. The 
data shown in Figure 1-6 establish that alkaline phosphatase can be used 
effectively to dephosphorylate glycogen synthase in heart extracts. 
Moreover, it was found that all endogenous glycogen synthase phosphatase 
activity could be completely inhibited by adding KF while alkaline phos­
phatase was still active on glycogen synthase under these conditions. 
Thus, it was possible to add precisely known amounts of phosphatase 
activity to extracts and study the rate of dephosphorylation of the 
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endogenous glycogen synthase. The rate of dephosphorylation was linearly 
proportional to both the added phosphatase activity and the concentration 
of glycogen synthase in the tissue extract. In succeeding experiments, 
we maintained constant amounts of glycogen synthase by varying the amount 
of extract used, and we added constant activity of alkaline phosphatase 
as judged by activity with p-nitrophenyl phosphate as substrate. KF 
was kept at 100 mM. 
The dephosphorylation of extract glycogen synthase was examined in 
three groups of rats. Figure 1-7 shows data collected from studies on 
normal, 48 hr fasted, and 48 hr fasted-24 hr refed male rats. Clearly, 
the effect of glycogen was not the same in these three groups. The 
fasted animals showed an increased and the refed animals showed a de­
creased sensitivity to glycogen inhibition of the dephosphorylation reac­
tion when compared to control animals. Increased sensitivity, shown in 
this figure by a decreased rate of dephosphorylation and virtually no 
effect of the added glycogen, is indicated because the amount of endogenous 
glycogen in the extracts was sufficient to inhibit the reaction fully. 
Decreased sensitivity, shown by a curve that has higher rates of de­
phosphorylation and requires higher concentrations of glycogen for 
inhibition, is found in refed animals. The refed animal group also 
displayed the greatest variability as a group and in the B section of 
Figure 1-7, the curves obtained from each individual animal are shown. 
The individual curves do not show a great deal of variability and it is 
suspected that another factor such as the rate of recovery from fasting 
or the amount of phosphorylase a in the extract may be responsible for 
variation between animals in this group. 
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Discussion 
Previous studies have shown that there is a good correlation between 
glycogen content and the activity of glycogen synthase (expressed as 
percent glycogen synthase I) in both skeletal muscle muscle and heart 
tissue (9, 10). Since the activity of glycogen synthase generally 
reflects the phosphorylation state of the enzyme (number of enzyme 
sites phosphorylated), the studies cited above indicate the importance 
of glycogen as a regulator of the phosphorylation state of glycogen 
synthase in vivo. In intact tissue, there is probably a constant turn­
over of protein-bound phosphate groups and, thus, the phorphorylation 
state of glycogen synthase is determined by the activity of various 
protein kinases and phosphatases. Glycogen produces significant ef­
fects on some protein kinases and phosphatase reactions in vitro (19-21) 
and it may be that all vivo effects of glycogen on the phosphoryla­
tion state of glycogen synthase are manifested through dephosphoryla­
tion reactions. 
Glycogen inhibition of glycogen synthase dephosphorylation has 
been known for several years. Recently, Nuttall et al. (22) observed 
that the glycogen effect on glycogen synthase dephosphorylation in heart 
extracts may be subject to nutritional and/or hormonal modulation. 
Extracts from fasted and insulin-treated animals showed different 
responses to added glycogen than did normal animals. It was not pos­
sible to determine whether such effects were attributed to the glycogen 
synthase or the protein phosphatase present in the extracts used for 
the study. The ratio of glycogen synthase to phosphatase may not have 
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been a constant in the reactions. 
The experiments reported here show that E, coli alkaline phosphatase 
can be used to assess the effects of glycogen on dephosphorylation of 
glycogen synthase. In experiments with purified glycogen synthase, 
it was shown that the oxidation state of glycogen synthase determined 
the effectiveness of glycogen as an inhibitor (Figures 1-2 and 1-5). 
The oxidized form of glycogen synthase required much higher concentra­
tions of glycogen to cause equivalent inhibition of the phosphatase reac­
tion. Analysis of purified heart glycogen synthase indicates that each 
subunit contains six to seven free sulfhydryl groups as cysteine resi­
dues. There is no evidence for any disulfide bonds in the purified en­
zyme. Oxidation of heart glycogen synthase may involve any one or more 
of the sulfhydryl groups and further work will be required to define the 
chemical nature of the oxidized enzyme. However, since oxidized 
glutathione can form a stable, modified enzyme, a possible mechanism for 
alterations in the oxidation state of glycogen synthase can be postulated 
in which the enzyme might exist as a mixed disulfide with glutathione. 
It has been reported that such mixed protein-glutathione adducts are 
found in many tissues and that the amounts of these products are related 
to both nutritional and hormonal treatments of the animals (16, 23). 
In order to determine if glycogen inhibition of glycogen synthase 
dephosphorylation occurs in intact heart tissue and if this phenomenon 
is altered in different nutritional or hormonal states, we have used 
alkaline phosphatase to study the dephosphorylation of heart glycogen 
synthase in tissue extracts (Figure 1-7). These studies essentially 
confirmed the observations made by Nuttall et al. (22), but since we 
48 
used E. coli alkaline phosphatase to catalyze the dephosphorylation in 
these extracts, the effects observed can be attributed to differences 
in the availability of phosphorylated sites in glycogen synthase. 
Fasted animals showed almost no effect of added glycogen. Since the 
rate of dephosphorylation was low compared to the other groups of 
animals, it may be that the glycogen synthase was inhibited by the low 
concentration of glycogen already present in the cell extract. Thus, 
these animals could represent a state in which the sulfhydryl groups 
in glycogen synthase were more reduced than normal. On the other hand, 
the effect of glycogen in fasted-refed animals was less pronounced than 
that in normal animals. This effect might be observed if the glycogen 
synthase was in a more oxidized state than normal. Since other factors 
can also influence the rate of dephosphorylation of glycogen synthase, 
it may be hasty to assume that glycogen effects can only be modulated by 
the oxidation state of glycogen synthase. However, in defense of this 
idea, it should be noted that no other effector of glycogen synthase 
dephosphorylation has shown any effect on the glycogen inhibition curve 
to date. Therefore, oxidation of glycogen synthase sulfhydryls remains 
the only known mechanism to cause differences in the response of this 
dephosphorylation reaction to glycogen. 
It is interesting to note that the importance of sulfhydryl groups 
in the relation of metabolism has been discussed frequently in the 
past. The importance of a thioredoxin-modulated regulator system in 
both plant and animal tissues has recently demonstrated the importance 
of such a system of regulation (24, 25). The presence of mixed adducts 
of protein and glutathione (cited earlier) also imply a second kind of 
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regulatory system for protein sulfhydryls. Therefore, it seems possible 
that the dephosphorylation state of glycogen synthase in heart tissue 
may be at times regulated by oxidation or reduction of sensitive sulfhy-
dryl groups in the enzyme. These effects could be manifested by an in­
creased or decreased rate of dephosphorylation in the absence of a 
change in the phosphorylation rate of the enzyme. 
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Figure I-l. Inhibition of alkaline phosphatase and protein phosphatase 
activity on glycogen synthase D by glycogen. Glycogen-free 
heart glycogen synthase was incubated with either 2 units/ml 
E. coli alkaline phosphatase (closed symbols) or with 5 
units/ml heart protein phosphatase (open symbols). The 
rate of dephosphorylation was determined by assay of the 
glycogen synthase activity as described in the Methods. 
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Figure 1-2. Effect of dithiothreitol on glycogen inhibition of the 
dephosphorylation of aged heart glycogen synthase. 
Glycogen-free glycogen synthase was aged for 8 weeks at 
-20° in the presence of dithiothreitol (•), or in its 
absence (0). Glycogen inhibition of the alkaline phos­
phatase- catalyzed dephosphorylation was determined as 
described in Figure I-l. The curve shown by closed tri­
angles (A) shows the curve for the glycogen synthase 
after aging and incubated overnight at -20° with 5 mM 
dithiothreitol. The upper numbers on the abscissa are 
for the curves with filled symbols, and the lower numbers 
are for the curve with open symbols. 
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Figure 1-3. Effect of glycogen synthase concentration on the rate of dephosphorylation of aged heart 
glycogen synthase. Glycogen-free glycogen synthase was treated as in Figure 1-2 and the 
rate of dephosphorylation by 1.5 units/ml alkaline phosphatase was determined as de­
scribed in the Methods after a lO-minute incubation of enzyme and substrate. Symbols 
are (#) glycogen synthase before aging, (o) enzyme aged without reducing agent, and (A) 
aged enzyme reduced with 5 mM dithiothreitol overnight at -20°. The concentration of 
glycogen synthase was 0.5 U/ml in the incubations. 
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Figure 1-4. Effect of oxidized glutathione (GSSG) on the activity of 
heart glycogen synthase. Glycogen-free glycogen synthase 
was incubated at -20° with the concentrations of GSSG 
shown in the figure. The concentration of glycogen syn­
thase was 4 units/ml. After two days, the activity of the 
enzyme was determined by the standard glycogen synthase as­
say with 10 mM glucose 6-P (o). All enzyme containing GSSG 
was diluted 125-fold without GSSG before assay of enzyme 
activity. The closed circles (•) show the activity of the 
enzyme after incubation with 20 mM dithiothreitol for 20 
min at room temperature. 
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Figure 1-5. Effect of GSSG on glycogen inhibition of glycogen synthase dephosphorylation. Glycogen-
free glycogen synthase was incubated at -20° with either (•) 100 pM GSSG for 8 weeks or 
with (•) 2 mM GSSG for 11 days. The GSSG was removed by a Sephacryl S-300 column (0.3 ml 
resin/150 M-l enzyme) before determining the rate of dephosphorylation with 1.5 units/ml 
alkaline phosphatase. For comparison, the glycogen Inhibition curve determined with the 
same enzyme stored for 8 weeks with 20 mM dithiothreitol is shown (o). The concentration 
of glycogen synthase was 0.5 U/ml in the incubations. 
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Figure 1-6. Dephosphorylation of glycogen synthase in heart extracts 
with E. coli alkaline phosphatase. Heart extracts pre­
pared as described in the Methods were incubated at 30° 
under the following conditions, and aliquots were taken 
at the indicated times to determined percent glycogen 
synthase I as described in the Methods, (A) The extract 
was incubated with no additions, but diluted with buffer 
to 0.3 units glycogen synthase/ml. (o) Extracts diluted 
as above, but 100 niM KF was added. (•) Extract diluted 
as above, with both 100 mM KF and 16 units/ml alkaline 
phosphatase added. 
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Figure 1-7. Effect of glycogen on dephosphorylation of glycogen syn­
thase in heart extracts. Extracts were prepared as 
described in the Methods from hearts of animals that were 
(•) fed ^  libitum, (a) fasted for 48 hr, or (o) fasted 
48 hr, and then allowed to feed freely for 24 hr. Ex­
tracts were diluted to 0.3 units/ml glycogen synthase, 
and both 5 units/ml alkaline phosphatase and 100 mM KF 
were added for enzyme incubations at 30°. Glycogen 
concentrations shown on the abscissa include both the 
amount of glycogen contributed by the heart extract as 
determined by phenolsulfuric acid methods, and the amounts 
of rabbit liver glycogen added to the reaction. The dif­
ference in the percent glycogen synthase I content before 
and after a ten-minute incubation is shown on the ordinate. 
Panel A shows the conçosite results of the analysis from 
four to seven animals in each group. Panel B shows re­
sults from individual animals in the fasted-refed group. 
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SECTION II: REGULATION OF BOVINE CARDIAC GLYCOGEN SYNTHASE I 
ACTIVITY BY SULFHYDRYL MODIFICATION 
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Introduction 
The rate-limiting enzyme in glycogen synthesis in mammalian tissues, 
glycogen synthase (Uridine diphosphate glucose:a-l,4-glucosyltransferase, 
EC 2.4.1.11), exists as several interconvertible forms (1-3). The 
interconversion is through phosphorylation-dephosphorylation reactions 
(1-12). Glycogen synthase including the cardiac enzyme are multiply 
phosphorylated (4-7), and can be phosphorylated by not less than three 
different protein kinases (4, 5, 8-11). There are at least three phos­
phorylation sites in each subunit of the cardiac enzyme (5). Two of 
these sites, namely site 1 and site 2, respectively, are phosphorylated 
by cAMP-dependent protein kinase (4), and the phosphorylation of the 
third site, site 3, is catalyzed by a cAMP-independent protein kinase 
(5). Dephosphorylation is catalyzed by a poorly understood glycogen 
synthase phosphatase (1, 12). 
Interconversion of the phospho- and dephospho- forms of glycogen 
synthase is mediated by hormones (13-15). Glycogen has been shown to 
have a significant effect on the phosphorylation state of glycogen 
synthase (2, 16, 17), presumably through inhibition of the dephosphoryla­
tion reaction (1, 18, 19). Glycogen inhibition of the dephosphorylation 
in cells may be subjected to nutritional and/or hormonal regulation (20, 
21). The existing evidence suggests that the inhibitory effect of 
glycogen on the dephosphorylation reaction is substrate-mediated (1, 
22). Our laboratory (23) recently reported that changes in the effect 
of glycogen on the dephosphorylation of cardiac glycogen synthase may 
be achieved by modifying the oxidation-reduction state of certain 
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cysteines in glycogen synthase. When the enzyme was oxidized with 
oxidized glutathione, the dephosphorylation of this oxidized substrate 
became less sensitive to glycogen inhibition. It has also been re­
ported that rat liver glycogen synthase could be modified by oxidized 
glutathione through sulfhydryl exchange (protein mixed-disulfide forma­
tion) (24). Oxidation of four of the eight sulfhydryl groups per sub-
unit of the rat hepatic phosphorylated glycogen synthase by oxidized 
glutathione led to enzyme inactivation and its dissociation from glycogen 
(25). These data suggest that the formation of protein mixed-disulfides 
may play an important role in the regulation of glycogen synthase 
activity and its interconversion reactions. 
Because of the possible significance of protein mixed-disulfide 
formation in the regulation of glycogen metabolism in heart, it is of 
interest to investigate the oxidation of glycogen synthase by low 
molecular weight disulfides. In this report, we examine the oxidation 
of bovine glycogen synthase I by oxidized glutathione. 
Materials and Methods 
Both reduced and oxidized glutathione, dithiothreitol, mercapto-
ethanol, cystamine, 5,5'-Dithiobis(2-nitro-benzoic acid) (DTNB), rabbit 
liver glycogen (type III), uridine 5'-diphosphate glucose, glucose-6-
phosphate, cysteine, Trizma (Tris(hydroxymethyl)-aminomethane), and EDTA 
were obtained from Sigma Chemical Company, St, Louis. Hydrogen peroxide 
and glycerol were purchased from Fisher Chemical Company, Cysteamine 
was from Aldrich Chemical Company. Reduce P-Nicotinamide Adenine 
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Dinucleotide (NADH) and cystine were the products of United States Bio­
chemical Company. Ammonium persulfate and ,N'-tetramethylene-
diamine were products of Canalco. Acrylamide and N,N'-methylene-
bisacrylamide were purchased from Bio-Rad Laboratories. Other chemicals 
were of reagent grade. 
Rabbit liver glycogen was treated with Amberlite MB-3 before use. 
[^ C^]-Uridine diphosphate glucose was prepared from [^ C^]-glucose ac­
cording to the procedure of Thomas et al. (26). 
Glycogen synthase I was purified from bovine heart according to 
Mitchell et al, (4), and was made glycogen-free by a procedure described 
by Mellgren (27), except that the glycogen-free enzyme was dialyzed 
against a buffer (50 mM Tris-HCl, pH 7.8, 5 mM EDTA, 50% v/v glycerol) 
containing no reducing agent for 2 days at -20° to remove the remaining 
reducing agents. 
Glycogen synthase activity was assayed in the presence of 10 mM 
glucose-6-P by the method of Thomas et al. (26). UDP-glc concentration 
in the standard assay was 5 mM, and had a specific radioactivity of 
42,000 cpm/ixmol. The Reduction Independence Ratio (RIR) of the enzyme 
is the ratio of enzyme activity assayed with a 10 min incubation 
without dithiothreitol to that incubated with 20 mM dithiothreitol. 
Glycogen-free glycogen synthase I was oxidized with oxidized 
glutathione as follows. Glycogen synthase I in a buffer containing 
50 mM Tris-HCl, pH 7.8, 5 mM EDTA and 50% v/v glycerol was incubated 
with 10 mM oxidized glutathione at -20° for days. The degree of 
oxidation was determined by following the Reduction Independence Ratio 
of the enzyme without prior removal of the oxidized glutathione. 
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Oxidized glutathione had no effect on the activity of glycogen synthase. 
In some cases, oxidized glutathione and low molecular weight materials 
were removed from glycogen synthase by gel filtration with a small 
Sephacryl S-300 column at 4°. A 0.2 ml sample was put over a 3-ml 
column, pre-equilibrated with the buffer containing 50 mM Tris-HCl, 
pH 7.8, 5 mM EDTA. and 25% v/v glycerol. The pooled enzyme fractions 
were concentrated by dialysis against the same buffer containing 50% 
v/v glycerol at -20° overnight. 
SDS-gel electrophoresis of the reduced and GSSG-oxidized glycogen 
synthase I were performed according to the method of Weber- and Osborn 
(28) except that no reducing agent was included. 
Protein sulfhydryl content was determined in the following manner. 
Protein sample (0.2 ml) was applied to a 3-ml Sephadex G-50 column which 
has been pre-equilibrated with 0.1 M sodium phosphate buffer (pH 8.0). 
The sample was eluted with the same phosphate buffer and 0.2 ml fractions 
were collected. The amount of protein sulfhydryl was determined by 
assay with DTNB (29). AHquots of each fraction (0.15 ml) were diluted 
to 0.5 ml with the same pH 8.0 sodium phosphate buffer, 5 |i.l of 10 mM 
DTNB in phosphate buffer was added and absorbance at 412 nm was deter­
mined. The molar concentration of protein sulfhydryl was calculated 
(taking the extinction coefficient of thionitrobenzoate ion as 13,600 
-1 -1 
M cm ) (29). Protein was determined according to Lowry et al. (30). 
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Results 
Inactivation of glycogen-free glycogen synthase 1 ^  oxidation with 
oxidized glutathione 
When glycogen-free glycogen synthase I was incubated with oxidized 
glutathione (GSSG) in a buffer containing 50 mM Tris-HCl, pH 7.8, 5 mM 
EDTA., 50% v/v glycerol at -20° for several days, the glycogen synthase I 
was inactivated. The inactivation was completely reversed by a short 
incubation with dithiothreitol (DTT) (Figure II-l). This suggests that 
the inactivation was a result of oxidation of sulfhydryl groups in 
glycogen synthase I. When glycogen-containing glycogen synthase I was 
used, no inactivation occurred. Because preincubation with 20 mM DTT 
completely reactivated the oxidized glycogen synthase I, the oxidation 
state could be judged from enzyme assays in the presence and absence of 
DTT. Reduction independence ratio (RIR) is the ratio of enzyme activity 
assayed after preincubation without DTT to that with 20 mM DTT. The 
concentration of DTT and the time for the reactivation were based on 
the results of Figure II-2. Incubation with 20 mM DTT for 5 min 
completely reactivated the GSSG-oxidized glycogen synthase I. The 
presence of 1 mg/ml rabbit liver glycogen had no effect on the time 
course of reactivation. As a result, the enzyme was routinely reactivated 
with 20 mM DTT in the presence of 1 mg/ml rabbit liver glycogen for 
10 min. 
Figure II-3 shows the time course of oxidation of glycogen-free 
glycogen synthase I with 10 mM GSSG at -20°. The rate of decrease in 
RIR of the enzyme was directly proportional to the time of reaction 
and to the concentration of GSSG use (data not shown). No inactivation 
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occurred in the absence of GSSG. The pH of the reaction buffer (50 
mM Tris-HCl, pH 7.8, 5 mM EDTA., 50% v/v glycerol) is temperature-
dependent (Figure II-4). The pH of the buffer at -20°, the temperature 
at which the GSSG-mediated oxidation was performed, was 8.8 while at 30°, 
it was 8.0. The pH and temperature of the reaction may be important. 
Since no inactivation of glycogen synthase I by GSSG occurred at 30°, 
the inactivation process may require a pH-dependent reaction, not simply 
peptide binding to the enzyme. 
Effect of pH on the oxidation (inactivation) 
Reactivity of protein sulfhydryls with low molecular weight di­
sulfides to form protein mixed-disulfides is more favorable in alka­
line conditions because a deprotonated sulfhydryl is needed to initiate 
the reaction of sulfhydryl-disulfide exchange with the low molecular 
weight disulfides (31). The effect of pH on the oxidation (inactivation) 
of glycogen-free glycogen synthase I by cystamine is shown in Figure 
II-5. Aliquots of glycogen-free glycogen synthase I were dialyzed 
against the Tris-glycerol buffers (50 mM Tris-HCl, 5 mM EDTA and 50% 
v/v glycerol) of different pH to equilibrate the enzyme to different 
pH, Cystamine-mediated oxidation of glycogen synthase I was more 
favorable at the alkaline pHs (pH higher than 7) than at neutral and 
acidic pHs. 
Effects of glycogen, uridine 5'-diphosphate glucose, and glucose-6-
phosphate on the GSSG-mediated inactivation (oxidation) 
It has been reported that rat liver phospho-form of glycogen 
synthase could be oxidized by GSSG through protein mixed-disulfide 
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formation (24), and that the oxidation could be protected by glucose-
6-P (25). Lin and Segal (7) also have shown that glycogen binding 
protected one protein sulfhydryl group per subunit of rat liver enzyme 
from DTNB reaction. It was of interest to investigate the effects of 
glycogen, uridine 5'-diphosphate glucose (UDP-glc), and glucose-6-P 
on the oxidation (inactivation) of cardiac glycogen synthase I by GSSG. 
Figure II-6 shows that either 10 mg/ml rabbit liver glycogen or 5 mM 
UDP-glc alone could completely prevent the inactivation of glycogen-
free glycogen synthase I by 10 mM GSSG. Glucose-6-P significantly 
retarded the rate of inactivation but did not prevent the reaction. 
Reaction of the protein sulfhydryls of cardiac glycogen synthase I 
with GSSG 
The number of protein sulfhydryl groups per subunit of cardiac 
glycogen synthase during the oxidation with 10 mM GSSG was measured 
by titration with DTNB. Low molecular weight substances were removed 
by gel filtration before the sulfhydryl determination. The reduced 
cardiac glycogen synthase contained about seven or eight cysteine groups 
per subunit, and there was no evidence of protein-protein disulfides. 
The number of protein sulfhydryls per enzyme subunit decreased during 
reaction with GSSG, as is shown in Figure II-7. Oxidation of a single 
protein sulfhydryl per subunit of the enzyme caused the loss of about 
60-70% of the enzyme activity (i.e., RIR dropped to about 0.3-0.4). 
Further oxidation of protein sulfhydryls had a much smaller effect on 
the enzyme activity. The number of protein sulfhydryls per synthase 
subunit was also determined during oxidation with 10 mM GSSG in the 
presence of 5 mM UDP-glc (Table II-l). Oxidation in the presence of 
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5 mM UDP-glc protected one protein sulfhydryl from oxidation and there 
was very little loss in enzyme activity. This suggests that UDP-glc 
protected one sulfhydryl that was very important in maintaining enzyme 
activity from oxidation. 
The possibility of formation of intersubunit disulfides during the 
GSSG-mediated oxidation was investigated by SDS-polyacrylamide gel 
electrophoresis under nonreducing conditions. The reduced glycogen 
synthase I (stored in 5 mM DTT), GSSG-oxidized enzyme, and the same 
oxidized enzyme after 20 min incubated with 20 mM DTT, had the same 
mobility with no evidence of oligomeric species. 
Specificity of oxidation (inactivation) 
The effectiveness of various low molecular weight disulfides as 
oxidizing (inactivating) agents was compared (Table II-2). DTNB was 
by far the most effective compound as 1 mM DTNB led to complete in­
activation after a few seconds. Cystamine was also a very effective 
oxidizing agent, and cystine reacted very little in 20 min. All these 
disulfide-mediated inactivations were completely reversible by a 10 min 
incubation with 20 mM DTT. Oxidized DTT was not an effective oxidizing 
agent. 
Hydrogen peroxide, which converts protein sulfhydryls to protein-
protein disulfides or to protein sulfenic acid (32), also inactivated 
glycogen synthase I at 30° (Figure II-8). This inactivation was not 
reversible by treatment with 20 mM DTT. 
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Specificity of reducing agents in the reduction of GSSG-oxidized 
glycogen synthase I 
As shown in Figure II-2, DTT is very effective in the reduction of 
the GSSG-oxidized glycogen synthase I. The specificity of various re­
ducing agents in the reduction of the oxidized enzyme has been examined 
(Table II-3). Of the reagents examined, DTT, mercaptoethanol, and 
cysteamine were shown to be very effective; but reduced glutathione 
(GSH), cysteine, and NADH were ineffective. 
In this study, two preparations of GSSG-oxidized glycogen synthase 
I were used. The first preparation had a RIR of 0.4, and the second 
preparation had a RIR of 0.2. With the first preparation, 20 mM GSH 
could only reactivate the enzyme slowly and slightly at 30°. The 
presence of 10 mg/ml of glycogen seemed to block the reactivation by 
GSH. This enzyme could not be reduced by cysteine. With the second 
preparation, neither GSH nor cysteine was effective in the reduction. 
In fact, incubation of this oxidized enzyme with either 20 mM GSH or 
20 mM cysteine for 20 min completely destroyed the enzyme activity. 
The 'dead' enzyme could not be revived by DTT treatment. Glucose-6-P 
protected the GSH-induced loss of enzyme activity, but not the cysteine-
induced inactivation. UDP-glc had a small protective effect against 
GSH but not cysteine. Glycogen offered no protection against either 
reducing agents. With either preparation, DTT, mercaptoethanol, and 
cysteamine could completely reactivate the enzyme, and neither substrate 
nor glucose-6-P had any effect. NADH was not a reducing agent for the 
GSSG-oxidized glycogen synthase. 
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Discussion 
Treatment of highly purified bovine cardiac glycogen-free glycogen 
synthase I with low molecular weight disulfides such as oxidized gluta­
thione resulted in enzyme inactivation. The disulfide-mediated enzyme 
inactivation could be reversed by a short treatment with dithiothreitol, 
indicating that the effects of low molecular weight disulfides were on 
the sulfhydryl groups of the enzyme. This study shows that the disulfide-
mediated inactivation of cardiac glycogen synthase is a result of co-
valent modification of protein sulfhydryl groups in glycogen synthase 
by a sulfhydryl-disulfide exchange reaction (protein mixed-disulfide 
formation). This conclusion is drawn from the following observations: 
(a) protein sulfhydryl groups in glycogen synthase were lost in a time-
dependent manner as a consequence of the reaction with GSSG (Figure II-7); 
(b) the loss of a single protein sulfhydryl per glycogen synthase sub-
unit was responsible for the loss of the majority of the enzyme activity 
(Figure II-7); (c) the disulfide-mediated enzyme inactivation could not 
be reversed by dialysis nor by gel filtration; (d) there was no evidence 
for inter-subunit disulfide formation; and (e) the disulfide-mediated 
enzyme inactivation was more favorable in alkaline pH (Figure II-5), 
a characteristic of the sulfhydryl-disulfide exchange reaction. 
The protein sulfhydryl essential for enzyme activity was the most 
reactive sulfhydryl of all seven or eight sulfhydryls in each subunit of 
the enzyme (Figure II-7). Further modification of other sulfhydryls in 
the enzyme had a much smaller effect on the enzyme activity. The GSSG-
mediated enzyme inactivation was protected by either substrate, UDP-glc 
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or glycogen (Figure II-6). Oxidation of glycogen-free glycogen synthase 
I with GSSG in the presence of UDP-glc still resulted in loss of pro­
tein sulfhydryls, but one less sulfhydryl per subunit of glycogen syn­
thase was modified than that in the absence of UDP-glc with no appreciable 
loss in enzyme activity (Table II-1). This suggests that modification 
of a single sulfhydryl per glycogen synthase subunit is responsible 
for the enzyme inactivation. 
Because the substrates could protect the enzyme from the GSSG-
mediated inactivation, the sulfhydryl group, important for enzyme 
activity, may be located at or close to the substrate binding sites, 
presumably the active site. Although the pH optimum of glycogen syn­
thase is around 8.0 (33), approximately the pKa of the sulfhydryl group 
of the protein cysteine, it is not likely that this sulfhydryl group 
directly involves in the enzyme catalysis, simply because modification 
of this sulfhydryl did not cause complete enzyme inactivation. There­
fore, this sulfhydryl group may be located at or near the active site 
but is noncatalytic, and binding of either substrate could cover it up. 
Alternatively, binding of either substrate may alter the enzyme conforma­
tion so that the particular protein sulfhydryl, although distanct from 
the active site, becomes inaccessible for the modification. 
Ernest and Kim (24, 25) have previously reported that rat hepatic 
phosphorylated form of glycogen synthase could be modified by formation 
of protein mixed-disulfides. Although both oxidations of the hepatic 
phospho-form of glycogen synthase and of the cardiac glycogen synthase I 
by GSSG resulted in a reversible enzyme inactivation, there are many 
differences between the two oxidation reactions. Reaction of four of 
the eight sulfhydryls per subunit of the hepatic enzyme through protein 
mixed-disulfide formation with GSSG were required to inactivate the en­
zyme (25), whereas modification of a single protein sulfhydryl per sub-
unit of the cardiac enzyme was responsible for the reversible enzyme 
inactivation. Modification of the first sulfhydryl in the hepatic enzyme 
had no effect on the enzyme activity, and reaction of the second sulf­
hydryl led to the loss of enzyme activity. Modification of the next 
two sulfhydryls resulted in release of the enzyme from the glycogen 
complex (25). Glucose-6-P offered protection against the GSSG-mediated 
inactivation of the liver enzyme. This protection offered by glucose-
6-P was dependent on the concentration of glucose-6-P (25). Glucose-
6-P retarded the rate of inactivation of the cardiac enzyme (Figure II-6), 
but was not able to completely protect it from the GSSG-mediated inactiva­
tion. Glycogen protected the inactivation of the cardiac enzyme but 
had no effect on the hepatic enzyme. Furthermore, the reaction rate of 
the oxidation of hepatic glycogen synthase was much faster than that of 
the cardiac enzyme. 
The effect of GSSG-mediated modification of the cardiac glycogen 
synthase I on its association with glycogen has not been examined in 
this study. Ernest and Kim (25) reported that modification of the 
third and fourth sulfhydryls by GSSG caused the dissociation of their 
enzyme from glycogen. Lin and Segal (7) also reported that binding 
of glycogen to the rat hepatic phosphorylated glycogen synthase pro­
tected one protein sulfhydryl per subunit of enzyme from DTNB reaction, 
and that this sulfhydryl group was one of the essential sulfhydryl 
groups for enzyme activity. Since glycogen is one of the substrates. 
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and since glycogen is an important regulator of the dephosphorylation of 
the enzyme (16-19), it is possible that modification of these sulfhydryls 
may have important effects on the regulation of the enzyme. We recently 
reported that reaction of purified bovine cardiac glycogen-free phos-
phorylated glycogen synthase with GSSG resulted in desensitization of 
its dephosphorylation to glycogen inhibition (23). Thus, modification 
of the sulfhydryl groups of the cardiac glycogen synthase may change 
its sensitivity to glycogen inhibition of its dephosphorylation by 
alteration of the binding property of the enzyme to glycogen. 
The reactivation (reduction) of the modified enzyme requires 
strong reducing agents, such as dithiothreitol, mercaptoethanol, and 
cysteamine. Physiological sulfhydryl reductants, such as cysteine and 
GSH, are not very effective (Table II-3). The reduction of protein 
mixed-disulfides is probably enzyme-mediated, and glutathione reductase 
has been suggested to be the enzyme to reduce the mixed-disulfides 
between glutathione and proteins in vivo (34). It is particularly 
interesting that the effect of cysteine and GSH on the reduction of 
the two preparations of GSSG-oxidized glycogen synthase I used in this 
study is different (Table II-3). According to Figure II-7, preparation 
A (RIR = 0.4) probably had only a single protein sulfhydryl modified by 
GSSG, and preparation B (RIR = 0.2) probably had more than one protein 
sulfhydryl modified. GSH and cysteine probably reduce the protein mixed-
disulfides through an exchange of the disulfide linkage, forming a 
reduced protein sulfhydryl and glutathione disulfide (GSSG) or cysteinyl-
glutathione (CySSG), respectively. If the enzyme had only one protein 
sulfhydryl group modified (as in preparation A), the reduction 
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by cysteine or GSH might either reduce the enzyme, or had no effect 
at all. If the enzyme had more than one protein mixed-disulfides in 
the same molecule (as in preparation B), the reduction by either 
cysteine or GSH might cause the newly reduced protein cysteine to 
attack the nearby protein mixed-disulfides resulting in the formation 
of protein-protein disulfides. Similar model for formation of protein-
protein disulfides was proposed by Ziegler and Poulsen (35). Formation 
of protein-protein disulfides in cardiac glycogen synthase might lead 
to an irreversible enzyme inactivation. The cysteine- and GSH-induced 
irreversible enzyme inactivation may be important in the regulation of 
the glycogen synthase activity in cells. The inactivation of glycogen 
synthase by formation of protein-protein disulfides may be one of the 
initial steps in the degradation of the enzyme. This covalent modifica­
tion, thus, may provide an important point of regulation of the enzyme 
activity by allowing the cells to control the activity either reversibly 
or irreversibly. 
The involvement of protein mixed-disulfide formation as a possible 
regulatory mechanism has received serious attention recently. Many 
enzymes (36-41) in addition to the hepatic glycogen synthase (24, 25) 
have been suggested to be regulated by the formation of protein mixed-
disulfides. Formation of such protein mixed-disulfides in these enzymes 
had dramatic effects on their catalytic activities. Furthermore, mixed-
disulfides between protein and glutathione or cysteine are present in 
high intracellular concentration in various mammalian tissues (34). 
Issacs and Binkley (42) reported that the liver cellular content of the 
protein-glutathione mixed-disulfides varied diurnally, and that the 
82 
diurnal variation was a function of the feeding schedule (43). They 
also demonstrated a good correlation between the diurnal variations in 
levels of cAMP, the cellular disulfide-sulfhydryl ratio, and the cellular 
protein mixed-disulfides (43). These observations suggest a possible 
regulatory role for the protein mixed-disulfide formation in cells. 
The rate of mixed-disulfide formation of bovine cardiac glycogen 
synthase I with GSSG is slow. Although the physiological role of such 
slow c ova lent modification of an enzyme is doubtful, however, it maybe still 
important because formation of protein mixed-disulfides in cells is 
mediated by enzymes. Several enzymes, such as oxido-reductase, 
glutathione-protein transhydrogenases, and sufflase (44-48) are able to 
catalyze the formation of protein mixed-disulfides in cells. The rate 
of enzyme-catalyzed formation of protein mixed-disulfide in glycogen 
synthase may be rapid and, thus, physiologically significant. On the 
other hand, because the reaction rate of glycogen synthase with cystamine 
is rapid, it is possible that cystamine or similar disulfides, instead 
of GSSG, are the physiological regulators for the cardiac glycogen 
synthase. 
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Table II-1. Effect of UDP-glucose on GSSG-mediated oxidation of 
glycogen-free glycogen synthase I 
Aliquots of glycogen-free glycogen synthase I were incu­
bated at -20° with additions as indicated. The Reduction 
Independence Ratios and the number of free protein 
sulfhydryl per subunit of glycogen synthase I were deter­
mined as described in the Methods. 
Addition Reduction Independence Ratio mole SH/mole ^ ^^ gybu^ it 
No addition 1.1 7.5+0.4 
(in 5 mM DTT) 
+ 10 mM GSSG 0.3 3.7 + 0.2 
+ 10 mM GSSG and 0.9 4.3 + 0.3 
5 mM UDP-glc 
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Table II-2. Specificity of disulfide compounds in the inactivation of 
glycogen-free glycogen synthase I 
Inactivation reactions were performed with 1 mM of 
indicated disulfides at 30°. Reduction Independence 
Ratios were determined without removing the disulfides 
at 10 sec and 20 min of the reactions, and the pH of 
incubations was 8.0 
Reduction Independence Ratio 
Disulfides 10 sec 20 min 
No addition 1.1 1.0 
DTNB 0.0 0.0 
Cys tamine 0.9 0.1 
Cys tine 1.0 0.7 
6SSG 1.0 1.1 
Table II-3. Specificity of reducing agents in reduction of GSSG-oxidized glycogen synthase I 
Two preparations of GSSG-oxidized glycogen synthase I, A and B, were used. Preparation 
A had a specific activity of 25 U/mg and preparation B had a specific activity of 30 
U/mg, before they were made glycogen-free. Both preparations were at least 95% active 
when assayed without glucose-6-P but with 14 mM Na2S04. Both preparations were oxi­
dized with 10 mM GSSG as described in the Methods. GSSG were then removed by dialysis 
at -20° for two days. For preparation A, glycogen was added to the GSSG-oxidized en­
zyme and then dialyzed at -20° overnight to allow the glycogen synthase to complex 
with glycogen. In preparation B, the effectors were simply added to the GSSG-
oxidized enzyme aliquots, and were preincubated for 20 min prior to the reduction 
reactions. 
All reducing agents were 20 mM and were freshly prepared, GSSG-oxidized glycogen 
synthase I was incubated with the Indicated reducing agents at 30° for 20 min, and 
Reduction Independence Ratios were determined as described in the Methods. 
G.S, I Reduction Independence Ratio 
Reducing agents prep. No addition + 10 mg/ml RLG + 5 mM UDP-glc + 10 mM Glc-6-P 
None A 0.4 0.2 — — 
B 0.2 0,3 0.3 0.2 
DTT A 1.0 1.1 — — 
B 1.0 1.0 1.0 1.0 
Mercaptoethanol A 0.8 1.0 - -
B 0.9 0.9 0.8 0,9 
Cysteamlne A — - - -
B 1.0 1.0 1.0 0.9 
Glutathione A 0.6 0.3 — — 
B a a 0.3b 0.3 
Cysteine A 0.3 0.2 — — 
B a a a a 
NADH A — — - — 
B 0.2 0.3 0.2 0.2 
E^nzyme activity was lost after the reduction reaction, and could not be restored by DTT 
treatment. 
M^ajority of the enzyme activity was lost during the reduction reaction. 
Figure II-l. Effect of dithiothreitol on GSSG-treated glycogen syn­
thase I activity. Five and a half U/ml glycogen-free 
glycogen synthase I was incubated with 10 mM GSSG at -20° 
in 50 mM Tris-HCl, pH 7.8, 5 mM EDTA, 50% v/v glycerol. 
Aliquots were withdrawn at the time shown and diluted 50-
fold with a buffer containing 50 mM Tris-HCl, 5 mM EDTA, 
1 mg/ml rabbit liver glycogen, 50 mM potassium fluoride, 
either with (A) or without (A) 20 mM dithiothreitol. 
Glycogen synthase activity was assayed in the presence 
of 10 mM glucose-6-P after 5 min preincubation at 30°. 
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Figure II-2. Reactivation of GSSG-oxidized glycogen synthase I with 
dithiothreitol. Panel A. Time course for the reactiva­
tion. Glycogen-free glycogen synthase I was oxidized 
with 10 mM GSSG until the Reduction Independence Ratio 
decreased to 0.33. GSSG was removed by gel filtration. 
Two U/ml of oxidized glycogen-free glycogen synthase I 
was preincubated with or without 10 mg/ml rabbit liver 
glycogen at 4° fors 30 min. The reactivation was started 
by addition of 20 mM dithiothreitol at 30°. (•) repre­
sents enzyme with no glycogen; (A) represents enzyme 
with 10 mg/ml rabbit liver glycogen added. Panel B. 
Concentration dependence. The same GSSG-oxidized glycogen 
synthase I was reactivated with different concentration of 
dithiothreitol at 30° for 5 min without glycogen added. 
The pH of the reactivation was 8.0. 
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Figure II-3. Time course for oxidized glutathione-mediated oxidation 
of glycogen-free glycogen synthase I. Three and a half 
U/ml of glycogen-free glycogen synthase I in 50 mM Tris-
HCl, pH 7.8, 5 mM EDTA, 50% v/v glycerol was incubated 
at -20° in the presence of 1 mM dithiothreitol (A), and 
with 10 mM GSSG (o). (•) represents the enzyme incubated 
with no addition. Degree of oxidation of glycogen syn­
thase was determined by the Reduction Independence Ratio. 
GSSG was not removed prior to enzyme assays. The pH of 
reaction was 8.8. 
REDUCTION INDEPENDENCE RATIO 
Figure II-4. Effect of temperature on the pH of Tris-glycerol buffer. 
The reaction buffer (50 mM Tris-HCl, pH 7.8 5 mM EDTA, 
and 50% v/v glycerol) was precooled to -20®. The pH 
and the temperature of the buffer were determined as the 
buffer was warmed up. The dotted line is the extrapola­
tion of the pH curve to subzero temperatures, and the 
arrow indicates the pH of this buffer at -20°. 
97 
9.0 
8.8 
8-6 
8.4 
1 
8.2 
8.0 » 
7.8 
-20 -10 0 10 20 30 
TEMPERATURE (<>C) 
Figure II-5. The pH dependence of the cystamine-mediated oxidation 
of glycogen-free glycogen synthase I. Two U/ml of 
glycogen-free glycogen synthase I each was dialyzed 
against the reaction buffer (50 mM Tris-HCl, 5 nM EDTA, 
50% v/v glycerol) with different pH at -20° overnight to 
equilibrate the enzyme aliquots to the desired reaction 
pH. The cystaminé oxidation was performed with 1 mM 
cystamine at 30°. The rate of oxidation was repre­
sented by the change of Reduction Independence Ratio in 
10 min. 
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Figure II-6. Effect of glycogen, uridine 5'-diphosphate glucose and 
glucose-6-phosphate on the GSSG-mediated oxidation of 
glycogen-free glycogen synthase I. GSSG-mediated oxida­
tion of glycogen-free glycogen synthase I was performed 
as described in the Methods. The reaction mixture con­
tained 10 mM GSSG with (a) no addition, (•) 5 mM uridine 
5'-diphosphate glucose, (#) 10 mg/ml rabbit liver glyco­
gen, or (•) 10 mM glucose-6-P. (a) represents the 
reaction mixture without GSSG. The pH of reaction was 
8 .8 .  
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Figure II-7. Effect of GSSG-mediated oxidation on the protein 
sulfhydryls of glycogen-free glycogen synthase I. 
The number of free protein sulfhydryls of glycogen-
free glycogen synthase I was determined as described in 
the Methods. Different symbols represent different 
preparations of glycogen synthase I. The glycogen syn­
thase I was incubated at -20° with 10 mM GSSG. At 
various times, aliquots of enzyme were taken out to 
determine Reduction Independence Ratios and number of 
free protein sulfhydryls. 
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Figure II-8. Inactivation of glycogen-free glycogen synthase I by 
hydrogen peroxide. Glycogen-free glycogen synthase I 
was incubated with (A) 1 nM hydrogen peroxide; (o) 100 
hydrogen peroxide; or (#) no addition at 30°. At 
10 min, half of the enzyme containing 1 pM hydrogen 
peroxide was treated with 100 pM hydrogen peroxide (D). 
At 20 tain, 20 mM dithiothreitol was added to each 
of the reactions as indicated by the arrow. The pH 
of reaction was 8.0. 
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SECTION III; DEPHOSPHORYLA.TION OF GLYCOGEN SYNTHASE IN RAT HEART 
EXTRACTS BY E. COLI ALKALINE PHOSPHATASE. USE OF 
AN EXOGENEOUS PHOSPHATASE TO STUDY SUBSTRATE-MEDIATED 
REGULATION OF DEPHOSPHORYIATION 
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Introduction 
The dephosphorylation of glycogen synthase, in which the physio­
logically inactive phospho-form of the enzyme is converted to the physio­
logically active dephospho-form, may be catalyzed by one or several 
glycogen synthase phosphatases (1-3). Therefore, studies to examine 
regulation of dephosphorylation of glycogen synthase in tissue extracts 
are complicated by the unknown nature of the enzyme catalyzing the reac­
tion. In spite of this difficulty, previous studies have shown that 
there is a good correlation between tissue glycogen content and the 
activity of the glycogen synthase (expressed as °U GSI*) in skeletal 
muscle (4), heart (3), and liver (5). In heart tissue, % GSI has been 
shown to relate closely to the phosphorylation state of the enzyme 
(6). Since glycogen is a significant inhibitor of many glycogen synthase 
phosphatases vitro (2, 7, 8), it has been postulated that in vivo 
effects of glycogen on the regulation of the phosphorylation state of 
glycogen synthase may be acting through the dephosphorylation reaction. 
Nuttall et al. (9) observed that glycogen inhibition of the glycogen 
synthase dephosphorylation was faster than normal in extracts from 
fasted rat hearts. Insulin-treatment reduced the effect of glycogen on 
the reaction. It was suggested that the regulation of glycogen synthase 
dephosphorylation may be subject to nutritional and/or hormonal control 
through changes in the effect of glycogen on this reaction. However, the 
authors could not determine whether such effects were attributed to 
glycogen synthase, to the protein phosphatase(s), or to both, because 
the concentration of glycogen synthase, and the concentration of protein 
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phosphatase in their experiments could not be controlled adequately. 
Clearly, it is necessary to measure the rate of dephosphorylation under 
conditions where substrate concentration is varied independently of the 
protein phosphatase concentration. This same research group recently 
reported (27) that the protein phosphatase activity in heart extracts 
was altered by similar treatments to those described earlier. These 
studies used purified heart glycogen synthase to assay the phosphatase 
activity. 
Mellgren et al. (10) showed that E. coli alkaline phosphatase can 
be used to dephosphorylate purified cardiac glycogen synthase. Glycogen 
inhibited the phosphatase reaction catalyzed by either heart protein 
phosphatase or the E. coli alkaline phosphatase, and the glycogen inhibi­
tion curves for the two phosphatase reactions were nearly identical. 
Glycogen did not inhibit the hydrolysis of p-nitrophenyl phosphate by 
alkaline phosphatase. These data suggested that glycogen inhibition of 
glycogen synthase dephosphorylation occurred through direct effects on 
the glycogen synthase when purified enzymes were used. 
We report here on the use of E. coli alkaline phosphatase to de­
phosphorylate heart extract glycogen synthase in order to examine the 
effect of glycogen on dephosphorylation of the glycogen synthase present 
in heart extracts of animals under various treatments. With KF added 
to inhibit the endogenous protein phosphatase activities, it was possible 
to dephosphorylate glycogen synthase in extracts with precisely controlled 
quantities of alkaline phosphatase activity. We show that the concentra­
tion of substrate (glycogen synthase) and the phosphorylation state of 
that enzyme both have significant effects on the rate of dephosphorylation. 
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Extracts prepared from rats with different nutritional backgrounds 
responded differently to added glycogen, and it is suggested that a 
stable change in glycogen synthase is responsible for this effect. 
Materials and Methods 
Materials 
E. coli alkaline phosphatase was obtained from Worthington Bio­
chemical Corp. (BAPF alkaline phosphatase). The enzyme was centrifuged 
and redissolved in 50 mM Tris, pH 7.8 at approximately 100 units/ml 
before use. Rabbit liver glycogen was purchased from Sigma Chemicals 
(type HI) and was treated with Amberlite MB-3 resin before use. 
Sephacryl S-300 resin was purchased from Pharmacia Corp. Other chemicals 
were obtained from Sigma Chemicals and were reagent grade. [^ C^]-Glucose 
1-P was purchased from New England Nuclear and [^ C^]-UDP-Glueose was 
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synthesized from [ C]-Glucose according to Thomas et al. (11). Puri­
fied bovine cardiac glycogen synthase was isolated according to Mitchell 
et al. (6), and was made glycogen-free according to Mellgren (12) . 
Preparation of heart extracts 
Male Sprague-Dawley rats (Hilltop Lab. Animals, Inc.) weighing 
about 200 gm were used in our experiments. The animals were kept in a 
temperature- and light-controlled room, and were fed on 4% mouse and 
rat diet (Teklad, Inc.). Food and water were available at all times. 
Fasted rats were without food for 48 hr before sacrifice. Adrouny and 
Russell (13) showed that cardiac glycogen levels plateaued after 48 hr 
of fasting. Fasted-refed animals were allowed to feed ^  libitum for 
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24 hr after the fast. All animals were killed between 10 a.m. and noon 
by anesthetizing with 50 mg/kg Seconal injected intraperitoneally. 
Hearts were freeze-clamped in liquid nitrogen after removal and stored 
at -80® until use. 
Extracts were prepared by homogenization in 2 volumes of 50 mM 
Tris, 5 mM EDTA., 5 mM EGTA, 100 mM KF, pH 7.8 buffer. Homogenates were 
centrifuged at 5,000 x g for 10 min and applied to small Sephacryl 
5-300 columns (1 ml resin/0.25 ml extract). Fractions containing the 
highest concentration of glycogen synthase (excluded fraction) and the 
lowest concentration of heat stable phosphatase inhibitory activity were 
used in our experiments. 
Enzyme assays 
Glycogen synthase activity was assayed by the method of Thomas et 
al. (11). Percent glycogen synthase I (% GSI) was determined by the 
ratio of enzyme activity with 14 mM Na^ SO^  to that of 10 mM glucose 
6-P. UDP-Glucose had a specific activity of 40,000 cpm/ijmol. Phos-
phorylase activity was measured according to the method of Gilboe et al. 
(14). The specific activity of glucose 1-P was 20,000 cpm/pmol. The 
total phosphorylase activity was assayed in the presence of 2 mM AMP, 
and the a form of the enzyme was assayed in the absence of the effector. 
E. coli alkaline phosphatase activity was assayed on p-nitrophenyl 
phosphate (15, 16). One unit of alkaline phosphatase activity is de­
fined as the amount of enzyme giving 1 pmol of inorganic phosphate 
from p-nitrophenyl phosphate per min at 30°. 
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Glycogen synthase deohosphorylatlon 
Glycogen synthase was dephosphorylated in mixtures containing the 
excluded Sephacryl column fraction (glycogen synthase at 0.30 U/ml), 
100 mM KF, 100 mM Na^ SO^ , 50 mM Tris, 3.7 mM EDTA, 3.7 mM EGTA and 
5 U/ml E. coll alkaline phosphatase (pH 7.8). The final reaction volume 
was 25 M>1. The reactions were started by the addition of alkaline 
phosphatase and were allowed to incubate at 30° for 10 min. They were 
stopped by a 5-fold dilution with a cold buffer containing 50 mM Tris, 
5 mM EDTA, 5 mM Dithiothreitol, and 1 mg/ml rabbit liver glycogen (pH 
7.8), and were kept on ice until the glycogen synthase activity was 
assayed (less than 20 minutes). Phosphatase activity was deteinnined 
from the rate of change of % GSI. 
Glycogen determination 
The tissue and column fractions were digested with 30% hot KOH. 
The glycogen concentration was determined after precipitation with cold 
66% ethanol. All glycogen solutions were determined by Phenol Sulfuric 
acid method (17) with glucose as standard. 
Results 
Dephosphorvlation of glycogen synthase in heart extracts 
Recently, our laboratory (10) reported that E. coli alkaline phos­
phatase can be used to dephosphorylate purified heart glycogen synthase. 
Glycogen synthase in rat heart extracts, however, could not be de­
phosphorylated either by endogenous phosphatases or by added E. coli 
alkaline phosphatase (data not shown). It was necessary to remove 
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low molecular weight inhibitors from these extracts by collecting the 
enzyme fraction excluded from small Sephacryl S-300 columns. A typical 
elution profile from such a column is shown in Figure lll-l. All ex­
tracts gave results identical with the example shown. That is, glycogen 
synthase and glycogen eluted from the Sephacryl column in the first frac­
tions, probably as glycogen-glycogen synthase complex, while heat stable 
glycogen synthase phosphatase inhibitory activity appeared in later frac­
tions, completely separated from the early glycogen synthase fraction. 
When the excluded fractions were passed through a second identical 
column, there was no apparent decrease in inhibitory activity of the 
excluded fraction. The nature of the inhibitory substances is not 
clear, but we have shown that heart tissue does contain a heat-stable, 
nondialyzable material that inhibits dephosphorylation by alkaline 
phosphatase. 
KF is known to be a potent inhibitor of many protein phosphatases 
(8, 18-20). To examine the effects of KF on the E. coli alkaline 
phosphatase-catalyzed dephosphorylation, two different substrates 
were used. Figure III-2 shows that KF does not inhibit the dephos­
phorylation of purified bovine cardiac glycogen synthase by alkaline 
phosphatase. With p-nitrophenyl phosphate as the substrate, KF activates 
the hydrolysis of the phosphate ester. The observed activation is most 
likely a result of an increased ionic strength since NaCl produced 
identical activation of p-nitrophenyl phosphatase activity of alkaline 
phosphatase (data not shown). 
Since KF could be used to inhibit the endogenous protein phospha­
tases, and since KF does not inhibit E. coli alkaline phosphatase, it 
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was possible to use the E. coli enzyme to dephosphorylate glycogen 
synthase in heart extracts. Figure III-3 shows that glycogen synthase 
in a Sephacryl-treated heart extract was readily dephosphorylated by 
both endogenous protein phosphatase and by added E, coli alkaline phos­
phatase. In the presence of 100 mM KF, the endogenous phosphatase 
activity was obliterated, but alkaline phosphatase activity was unaf­
fected. Alkaline phosphatase could completely dephosphorylate the 
glycogen synthase in the extract. 
The result, shown in Figure 1II-3, indicated that alkaline phos­
phatase could be used to study glycogen synthase dephosphorylation in 
extracts containing endogenous protein phosphatase. The amount of phos­
phatase activity and the concentration of glycogen synthase in each reac­
tion mixture could be controlled precisely and independently because 
the endogenous protein phosphatase activity could be completely inhibited 
by KF. The effect of both glycogen synthase and alkaline phosphatase 
concentration on the rate of glycogen synthase dephosphorylation could 
easily be determined. The rate of dephosphorylation was proportional 
to the concentration of alkaline phosphatase (Figure III-4), and the 
time course of reaction was linear up to 50% GSI. In subsequent experi­
ments, 1 to 5 U/ml of E. coli alkaline phosphatase was used routinely 
to dephosphorylate extract glycogen synthase, and the rate of glycogen 
synthase dephosphorylation was calculated from single time assays where 
the glycogen synthase activity after dephosphorylation was less than 
50% GSI. The concentration of glycogen synthase also had important ef­
fects on the rate of dephosphorylation, and it was important to maintain 
a constant amount of glycogen synthase in all dephosphorylation reactions. 
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Normally, one would like to put equal amounts of the substrate form of 
glycogen synthase (phosphorylated) into each reaction. However, 
determining the phosphorylation state of glycogen synthase in crude 
extracts depends on measuring % GSI. This value does not necessarily 
assess the actual phosphorylated state of the enzyme, and our experi­
ments have been designed to maintain a constant total activity of 
glycogen synthase in each dephosphorylation reaction. We chose 0.3 
units/ml as a conveniently attained concentration. Normal heart glycogen 
synthase concentration is approximately 1.3 units per gram tissue. 
Many phosphoprotein phosphatases can dephosphorylate both glycogen 
synthase and phosphorylase (21-23). Our experiments (10) have shown 
that E. coli alkaline phosphatase is able to dephosphorylate purified 
cardiac glycogen synthase D, but not purified muscle phosphorylase a. 
In crude heart extracts, glycogen phosphorylase also was not dephos-
phorylated by alkaline phosphatase. Thus, the concentration of phos­
phorylase a in any tissue extract, did not change vftiile the dephosphoryla­
tion of glycogen synthase was being studied. Any effect of phosphorylase, 
either inhibitory or activating, on the reaction would be constant and 
unchanging. The amounts of phosphorylase a in extracts from different 
animals showed some variation, and this may account for some variation 
in the rate of dephosphorylation of glycogen synthase. 
Effects of glycogen on the rate of dephosphorylation of glycogen synthase 
in rat heart extracts 
It has been known for several years that glycogen inhibits the 
dephosphorylation of glycogen synthase (2, 7, 8). The alkaline 
phosphatase-catalyzed dephosphorylation of glycogen synthase was 
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inhibited by glycogen to the same extent as the reaction catalyzed by 
a protein phosphatase (10). Therefore, the effects of glycogen on the 
dephosphorylation of glycogen synthase in heart extract could be studied 
with alkaline phosphatase. 
Endogeneous glycogen was present in all extracts containing glycogen 
synthase, making it impossible to establish a basal rate of dephosphoryla­
tion with no inhibition by glycogen. Thus, inhibitory effects of 
added glycogen were computed by comparing effects relative to a basal 
rate that may have been already partially inhibited by endogenous glyco­
gen. Figure III-5 shows a typical experiment to determine the ef­
fect of added rabbit liver glycogen on the dephosphorylation of glycogen 
synthase in an extract from a normal rat heart. The concentration of 
endogenous glycogen in this experiment, after appropriate dilution of 
the heart extract to give 0.3 U/ml glycogen synthase, was 0.45 mg/ml. 
The concentration reported in the figure is the total amount of glycogen 
in the reaction, including the endogenous glycogen. Panel A shows that 
the rate of the dephosphorylation reaction decreased from a 20% GSI 
increase in 10 minutes with no added glycogen to an 8% GSI increase with 
saturating glycogen. Panel B expresses these data relative to the basal 
rate of dephosphorylation with no added glycogen. A maximum inhibition 
of approximately 60% was observed. The inhibition is comparable to that 
observed earlier with purified glycogen-free cardiac glycogen synthase 
(10). Thus, the endogenous glycogen in the heart extract may have been 
too low to produce a significant inhibition of this reaction. 
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Effects of fasting on glycogen synthase dephosphorylation by alkaline 
phosphatase 
Percent GSI in intact heart tissue has been related to the glycogen 
content of that tissue. For instance, Adolfsson et al. (24) showed that 
% GSI decreased as the glycogen content increased. Insulin increased 
the % GSI at all glycogen concentrations. This relationship has been 
attributed to a direct effect of glycogen on glycogen synthase dephos­
phorylation. Nuttall et al. (9) observed that glycogen inhibition of 
glycogen synthase dephosphorylation in rat heart was related to the hor­
monal and nutritional state of the animal. The rate of dephosphoryla­
tion was increased in fasted animals. Our experiments were designed to 
examine this effect with alkaline phosphatase. Three nutritional treat­
ments for groups of rats were used to compare the inhibitory effects of 
glycogen on glycogen synthase dephosphorylation. The heart tissue from 
these animals was first analyzed for glycogen synthase and phosphory-
lase activities, and for glycogen content to provide a basis for dephos­
phorylation experiments. Some of the data are summarized in Table III-l. 
The total glycogen synthase (as well as the total phosphorylase) activity 
in each heart extract was quite constant for rats in all nutritional 
groups. The glycogen synthase assayed as approximately 22% GSI in 
both normal and refed animals. This may indicate a similar state of 
phosphorylation in these two groups of animals. Fasted animals con­
tained approximately 5% GSI, indicating that the enzyme was more highly 
phosphorylated. Sephacryl column treatment did not affect the % GSI 
in these extracts. The glycogen content in hearts of fasted rats was 
much higher than in either normal or refed animals. The ratio of 
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glycogen synthase activity to glycogen content was greatest in normal 
animals, lower in refed animals and lowest in fasted animals. By 
treating extracts with Sephacryl columns, the glycogen synthase activity 
to glycogen ratio was increased for each group of animals. 
To characterize the glycogen synthase in hearts from the various 
groups of animals, studies on glucose 6-P activation were undertaken. 
Figure III-6 shows a study in which glucose 6-P was varied in the 
2+ presence and absence of 5 mM Mg . Previous data from our lab have 
2+ 
shown a major effect of Mg on the activation of purified heart glyco­
gen synthase by glucose 6-P (25). All data give quite linear kinetic 
2+ plots except the data obtained with fasted rats in the presence of Mg 
Table III-2 summarizes data from several animals in each nutritional 
group. The affinity for glucose 6-P was similar for both normal and 
refed animals. Inasmuch as the % GSI of these animals also is similar, 
the effect of glucose 6-P provides additional evidence that the phos­
phorylation state of these two groups of animals was similar, if not 
identical. In our previous studies with purified glycogen synthase, 
we found that identical assays for % GSI could be obtained with enzymes 
containing phosphate in different phosphorylatable sites (26). However, 
enzymes phosphorylated in different sites showed different affinities 
2+ for glucose 6-P. Mg increased the affinity of glycogen synthase for 
glucose 6-P by comparable amounts for these two groups of animals. The 
affinity of the enzyme from fasted animals for glucose 6-P was over four-
2+ fold less and Mg produced curvilinear kinetics. These data are in 
keeping with the idea that this more highly phosphorylated enzyme has 
phosphate on enzyme sites that are not present in enzymes from normal 
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or refed animals. Thus, it is likely that the glycogen synthase in 
normal and refed animals is similar in phosphorylation state while that 
in fasted animals is quite different. 
To examine regulation of dephosphorylation by E. coli alkaline 
phosphatase in each group of animals, we determined the effect of 
glycogen synthase concentration at a constant glycogen concentration 
(Figure III-7). The glycogen concentration in each tissue extract was 
determined, and additional rabbit liver glycogen was added to each reac­
tion to maintain 1 mg/ml glycogen. The rate of dephosphorylation was 
determined by an increase in the % GSI after incubation for the length 
of time indicated. It is not possible to compare the effect of glycogen 
synthase concentration between animals in different nutritional states 
in this particular experiment because each animal contained glycogen 
synthase with a different % GSI, i.e., state of phosphorylation. The 
apparent observed approximate the tissue concentration of glyco­
gen synthase. However, the dephosphorylation rate was fastest at all 
concentrations of glycogen synthase for animals with highest % GSI. 
The difference in rate was apparently caused by both a higher catalytic 
rate and greater affinity (K^ ) for the substrate, GSD. Therefore, in 
dephosphorylation studies, the rate of dephosphorylation is affected by 
the concentration of glycogen synthase and by the state of phosphoryla­
tion of the enzyme. It is important to compare dephosphorylation rates 
only in tissue extracts containing glycogen synthase with similar °U GSI. 
Figure III-8 shows a comparison of the inhibitory effects of 
glycogen on the dephosphorylation of glycogen synthase. In this study, 
extracts from all animals were dephosphorylated by alkaline phosphatase 
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at a constant concentration of glycogen synthase (0.3 units per ml), 
while the amount of glycogen was varied by adding rabbit liver glycogen. 
The % GSI of the animals used in this study is shown in Table III-l. 
The composite results of this experiment show that extracts from refed 
animals generally were less sensitive to glycogen inhibition than were 
extracts from normal animals. Extracts from fasted animals responded 
only slightly to added glycogen. When the glycogen level was increased 
above 5 mg/ml, the rate of dephosphorylation of extracts from fed animals 
was identical with that frcm fasted animals. Similarly, the rate of 
dephosphorylation of the extracts from refed animals was the same as for 
the other two groups when the glycogen concentration was brought to 20 
mg/ml (data not shown). These results suggest that the dephosphoryla­
tion of glycogen synthase in the extracts from the fasted rat hearts is 
nearly maximally inhibited by the endogenous glycogen while it takes very 
high concentrations of glycogen to maximally inhibit extracts from refed 
animals. Thus, the dephosphorylation reaction in the fasted heart might 
be very sensitive to glycogen inhibition, in refed hearts, it is quite 
insensitive, and in normal animals, the response is intermediate. 
Using the lines drawn in Figure III-8 as the average representation 
of the data, one can calculate the relative inhibition curves for the 
fed and refed animals. The rate of dephosphorylation with no added 
glycogen (approximately 0.5 mg/ml endogenous glycogen under assay 
conditions) was assumed to be the basal rate for calculation of the 
relative amount of inhibition. Figure III-9 compares the inhibition 
curves for fed and fasted-refed animals. These groups are compared 
because the glycogen synthase had simiLlar properties (Table III-l), 
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Low concentrations of added rabbit liver glycogen were more inhibitory 
to the fed animals. When glycogen was increased as high as 25 mg/ml, 
extracts from refed animals did not give the same relative inhibition 
as those from the fed animals since the basal rate of dephosphorylation 
was higher for the refed animals. Using the same basal rate of de­
phosphorylation for both animal groups, one can recalculate the 
inhibition at 20 mg/ml glycogen. With the basal rate equal to that for 
the refed animals, maximum inhibition for the refed animals was 607» and, 
for normal animals, 63%. This inhibition is strikingly similar to that 
reported earlier for purified, glycogen-free heart glycogen synthase 
(10). 
Discussion 
E. coli alkaline phosphatase can be used to advantage to study regula­
tion of glycogen synthase dephosphorylation. The reaction is not in­
hibited by KF while endogenous protein phosphatases in rat heart ex­
tracts are inhibited. Therefore, it is possible to regulate the concentra­
tion of a) phosphatase, b) glycogen synthase, and c) glycogen in each 
enzyme incubation. In addition, glycogen phosphorylase is not a 
substrate for E. coli alkaline phosphatase and remains unchanged during 
dephosphorylation of glycogen synthase. The dephosphorylation reaction 
is inhibited by glycogen, showing the same concentration effects as 
the reaction catalyzed by a protein phosphatase. There also is evidence 
from our experiments that heat-stable phosphatase inhibitory proteins 
in heart extracts act on the alkaline phosphatase-catalyzed reaction. 
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Further studies on the effects of purified inhibitory proteins will be 
needed to confirm this observation. Taken together, these observations 
indicate the general utility of E. coli alkaline phosphatase for 
studying glycogen synthase dephosphorylation. Indeed, a preliminary 
atten^ t to use alkaline phosphatase with rat liver extracts was success­
ful. Since liver tissue normally contains a high concentration of 
glycogen, it was necessary to use tissue from fasted animals to suc­
cessfully study dephosphorylation. 
Some interesting aspects of regulation of glycogen synthase de­
phosphorylation are very difficult to study because the inherent error 
in determining the rate of dephosphorylation could be as high as 5%. 
Subtle effects on the rate of dephosphorylation are impossible to ob­
serve under these conditions. It is clear, however, that the inhibitory 
effect of glycogen on glycogen synthase dephosphorylation can be studied 
by our methods, and changes in the effect of glycogen could be observed 
in heart extracts. 
The results presented here on glycogen inhibition of dephosphoryla­
tion extend those of Nutta11 et al. (9). In their work, it was reported 
that glycogen was more inhibitory to dephosphorylation of glycogen 
synthase in heart extracts from fasted rats than from normal rats. The 
study was done with the glycogen synthase and protein phosphatase that 
were present in the heart extracts, and it was not possible to determine 
if the observed effect was due to changes in phosphatase activity, 
glycogen synthase, or both parameters. In a subsequent study (27), 
this same research group has reported that some of the effects of 
fasting could be ascribed to changes in the glycogen synthase phospha-
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tase activity since purified heart glycogen synthase was added to ex­
tracts as a substrate for dephosphorylation. In our study, it was 
possible to study dephosphorylation of heart glycogen synthase with a 
phosphatase that is unaffected by glycogen (10). Since glycogen was 
quite inhibitory to dephosphorylation of glycogen synthase in extracts 
of normal, fasted, and fasted-refed animals, it is clear that this 
regulatory effect is due to an inhibitory complex of glycogen and heart 
glycogen synthase. The effect of glycogen was similar with extracts 
from all animals, but the differences observed are large enough to 
represent a significant regulatory effect in heart glycogen synthesis. 
The effects of glycogen on glycogen synthase dephosphorylation 
might represent a) a differential effect of glycogen on dephosphorylation 
of different phosphorylated sites in glycogen synthase, or b) a dif­
ferential effect of glycogen due to some change in glycogen synthase 
not related to the phosphorylation state of the enzyme. A clear example 
of the first case seems to result in the differences in the effect of 
glycogen on fasted animals. The glycogen synthase in these animals was 
more highly phosphorylated than that in normal animals by two different 
criteria. The % GSI was lower and the  ^glucose 6-P was higher than 
in normal animals. Therefore, although other effects on glycogen 
synthase can still be important, a different phosphorylated state is 
surely present, and dephosphorylation of the enzyme may reflect activity 
on different phosphorylated sites. An argument can be made that fasted-
refed animals are an example of the second kind of effect of glycogen 
in this system. Since both the % GSI and the Aq 5 glucose 6-P are the 
same for the glycogen synthase in normal and in fasted-refed animals. 
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the differential effects of glycogen would seem to result from something 
other than the phosphorylated sites on the enzyme. Recently, we reported 
(28) that the effect of glycogen on heart glycogen synthase dephos-
phorylation could be altered by changes in the oxidation state of glyco­
gen synthase sulfhydryls. We showed that oxidation of the enzyme led 
to a requirement for a higher concentration of glycogen to achieve 
inhibition of dephosphorylation. Maximum inhibition by glycogen was 
unchanged by oxidation. The oxidized form of the enzyme gave glycogen 
inhibition curves similar to those reported here for extracts from 
normal rat hearts. Fully reduced glycogen synthase was fully inhibited 
by glycogen at very low concentrations, similar to the effects ob­
served in fasted animals in the present study. Therefore, it seems 
possible that the changes in glycogen inhibition reported in this 
study may be related to alterations of the oxidation state of heart 
glycogen synthase in vivo. 
It should be noted that binding of glycogen to liver glycogen 
synthase also has been related to the state of oxidation of that euzyme 
(29, 30). In these studies, glycogen affinity was affected by oxidation 
of a single glycogen synthase sulfhydryl group. This result implies 
that a glycogen inhibition of the dephosphorylation of liver glycogen 
synthase also may be found to be regulated by a process similar to 
that described here. 
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Table III-l. Glycogen synthase activity and glycogen content of hearts 
from rats in different nutritional states 
Glycogen synthase activity and glycogen content were 
determined as described in the Methods. The average 
value for 6 rats in each group is indicated along with 
the standard deviation of these data. 
Normal 48 hr 48 hr fasted/ 
fed fasted 24 hr refed 
Glycogen synthase activity 
In heart (U/gm wet tissue) 
In Sephacryl-treated extract 
(U/ml) 
1.22+0.15 1.35+0.21 
0.37+0.09 0.41+0.06 
22.2 +4.4 4.7 +0.8 % GSI in tissue 
Glycogen concentration 
In heart (mg/gm wet tissue) 4.14+0.48 8.37+0.39 
In Sephacryl-treated extract 
(mg/ml) 
Glycogen synthase activity/ 
mg glycogen 
In heart (U/mg) 
In Sephacryl-treated extract 
(U/mg) 
0.68+0.09 1.88+0.21 
0.29+0.05 0.16+0.03 
0.54+0.15 0.22+0.04 
1.34+0.21 
0.43+0.11 
22.8 +3.9 
5.95+0.59 
1.05+0.23 
0.23+0.04 
0.41+0.14 
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Table III-2. Summary of glucose 6-P activation constants for rat heart 
glycogen synthase 
Aq.s for glucose 6-P for glycogen synthase in each rat 
heart extract was determined from the double reciprocal 
plot as shown and described in Figure III-6. Each group 
of animals consisted of 3-6 rats. 
AQ  ^for Glc 6-P (mM) 
Animals % GSI - + 5 mM free Mg++ 
Normal fed 22.5 + 2.3 0.38 + 0.15 0.15 + 0.06 
48 hr fasted 7.7 + 2.7 1.81 + 0.57 (curved) 
48 hr fasted-
24 hr refed 22.8 + 1.9 0.40 + 0.03 0.20 + 0.02 
Figure III-l. Elution profile of rat heart extracts from Sephacryl S-300. The extract was treated 
with a 1 ml column of Sephacryl (0.25 ml extract) and 0.2 ml fractions were col­
lected. Glycogen synthase and glycogen were described in the Methods. Column frac­
tions to be assayed for heat-stable phosphatase inhibition activity were placed in 
boiling water for 10 min and insoluble material was removed by centrifugation. Super­
natant was added directly to assay mixtures for glycogen synthase dephosphorylation 
with E. coli alkaline phosphatase (described in the Methods). These assays employed 
the excluded fraction (labeled 1 on the figure) as a source of glycogen synthase. 
Each 15 M-l phosphatase incubation contained 3 pi of the inhibitory fraction. The 
data are the average values for nine preparations from normal rat hearts, and 
standard deviations are indicated. Data are: (o) glycogen concentration, (A) glyco­
gen synthase, and (x) the heat-stable phosphatase inhibitory activity. 
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Figure III-2. The effect of KF on alkaline phosphatase activity with 
two different substrates. (A) Purified bovine cardaic 
glycogen synthase (0.5 U/ml, prepared as in the 
Materials) was dephosphorylated at 30° for 10 min by 2.5 
U/ml E. coli alkaline phosphatase in the presence of 
the concentrations of KF indicated. With no KF phos­
phatase activity on purified glycogen synthase in­
creased the activity by 15% GSI. (o) One millimolar 
p-nitrophenyl phosphate was also dephosphorylated at 
30° for 5 min by 1.6 U/ml E. coli alkaline phosphatase. 
The activity of alkaline phosphatase on both substrates 
with no KF was regarded as 100% activity. 
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Figure III-3. The effect of KF on the dephosphorylation of glycogen 
synthase in extracts. An extract was prepared from 
normal rat heart as described in the Methods except 
that KF was omitted in the homogenizing buffer. Be­
cause the extract had no KF, the °L GSI at zero time was 
somewhat higher than usual, i.e., 30% GSI instead of 
20% GSI. The figure shows the time course of the de­
phosphorylation of glycogen synthase in the extract with 
(A) no addition, (o) 100 mM KF, (•) 100 mM KF and 16 
U/ml alkaline phosphatase. Zero time points were 
determined at 30 sec after the reaction was started. 
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Figure III-4, The effect of alkaline phosphatase concentration on the dephosphorylation of heart 
extract glycogen synthase. An extract glycogen synthase from a normal rat heart 
was dephosphorylated by various concentrations of alkaline phosphatase. Assay methods 
are as described in the Methods, with 0.3 U/ml glycogen synthase. The rate of 
phosphorylation was determined after 10 min incubation at 30°. 
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Figure III-5. The effect of glycogen on the rate of dephosphorylation of glycogen synthase. A 
normal male rat was used to prepare an extract that contained 21% GSI as described in 
the Methods. The concentrations of glycogen indicated in the figure are the sum of 
the endogenous glycogen (0.45 mg/ml) contributed by heart extract and the added rabbit 
liver glycogen. Panel A shows the effect of added rabbit liver glycogen on the rate 
of dephosphorylation. Panel B shows the inhibition by glycogen relative to the rate of 
the reaction with no glycogen added. Reaction conditions were described in the 
Methods. 
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Figure III-6. Effect of glucose 6-P on glycogen synthase from fed, 
fasted, and fasted-refed rats. Heart extracts from 
animals were prepared as described in the Methods, 
Suitably diluted extract containing glycogen synthase 
activity was added to a reaction mixture to give 50 mM 
Tris, 4.28 mM EDTA, 0.71 œM'eGTA, 14.3 mM KF (pH 7.8), 
4.6 mM UDPG (2.5 x 10^  cpm/wnole), 1 mg/ml rabbit 
liver glycogen and various concentrations of glucose 
6-P. Each assay was incubated for 3 min in order to 
maintain linear reaction rates during the assay. Panel 
A shows double-reciprocal plots for a normal fed (o), a 
48 hr fasted (A) and a 48 hr fasted-24 hr refed (•) rat. 
is the difference in activity with and without glucose 
6-P at each indicated concentration. Panel B shows the 
double-reciprocal plots for the same extracts except 
that 5 inM free Mg++ was included in the assays. 
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Figure III-7. Effect of glycogen synthase concentration on the dephosphorylation of glycogen synthase 
by E. coll alkaline phosphatase. Extracts of rat hearts from normal fed (•, •), fasted 
(o, •) and fasted-refed (A, A, ®) rats were prepared as described in the Methods. 
Dephosphorylation was carried out in the presence of 50 mM Tris, pH 7.8, 5 mM EDTA, 
5 mM EGTA, 125 mM Na2S0/^ , 133 mM KF and 1 mg/ml of glycogen. The amount of glycogen 
in each extract was determined prior to each experiment and rabbit liver glycogen was 
Included in total to give 1 mg/ml. The reaction was started by adding alkaline phos­
phatase. The reaction was stopped by diluting with ice-cold buffer containing 80 mM 
Tris, pH 7.8, 5 mM EDTA, 5 mM DTT, and 50 mM KF. Other reaction conditions are de­
scribed in the Methods. The velocity is expressed as mU of glycogen synthase I formed 
per min with one unit of alkaline phosphatase, i.e., the specific activity of alkaline 
phosphatase for each extract. Initial % GSI for each extract was: (•) 17%, (o) 12%, 
(a) 23%, (•) 24%, (A) 28%, (A) 35%, and (®) 35%. The final glycogen synthase activity 
in all reactions was less than 50% GSI. 
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Figure III-8. The effect of rabbit liver glycogen on the dephosphoryla-
tion of glycogen synthase in rat heart extracts from 
animals in different nutritional states. Extracts were 
prepared from hearts of animals that were fed (•), fasted 
48 hr (A) and fasted 48 hr then refed 24 hr (o). The 
reaction conditions are described in the Methods. The 
effect of glycogen on the rate of change in 7» GSI for 
each animal is shown in the figure. The lines depict 
estimates of the composite effect of glycogen for each 
group of animals. The total glycogen concentration shown 
on the figure is the sum of endogenous glycogen in the 
extracts and any added rabbit liver glycogen. Fed ex­
tracts contained an average of 0.68 mg/ml glycogen, 
fasted contained 1.9 mg/ml and fasted-refed contained 
1.1 mg/ml. 
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Figure III-9. Relative inhibitory effects of glycogen dephosphorylation of glycogen synthase from fed 
and fasted-refed rats. The data points were obtained from the lines drawn in Figure 
III-8. These were used as the average for the data for each group of rats, (o) normal 
fed rats; (•) fasted-refed rats. The reaction rate for both groups of animals at 0.5 
mg/ml glycogen concentration was taken as the basal rate for calculation of percent 
inhibition (basal rates; fed — 16% GSI change, fasted-refed — 22% GSI change). 
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DISCUSSION 
The activity of glycogen synthase, the key enzyme in glycogen 
synthesis in mammals, is regulated at three levels. The first level 
of control is regulated by the cellular concentration of the substrate, 
UDP-glucose (217-219). The second level of regulation is through 
the allosteric control of the enzyme by various effectors (8, 58-62). 
The third level of control, which is believed to be of the most physio­
logical importance, is through phosphorylation-dephosphorylation reac­
tions (18-20). The hormonal control of glycogen synthesis in mammalian 
tissues including heart is mediated through the control of the phos-
phorylation-dephosphorylation of glycogen synthase (12, 13). This work, 
however, suggests yet another possible mode of regulation of glycogen 
synthase activity, namely, through protein mixed-disulfide formation. 
Glycogen has been shown to be an important regulator of glycogen 
synthase dephosphorylation (118, 119, 162-165). The inhibitory effects 
of glycogen on glycogen synthase dephosphorylation are thought to be 
substrate-mediated (118, 147, 165). Mellgren (39) recently reported 
that the amount of glycogen required to maximally inhibit the de­
phosphorylation reaction depended on the purity of the glycogen synthase 
used. Dephosphorylation of a partially purified bovine cardiac phos­
phorylated glycogen synthase was relatively insensitive to glycogen 
inhibition whereas dephosphorylation of a highly purified homogeneous 
bovine cardiac phosphorylated glycogen synthase was much less sensitive 
to glycogen inhibition (39). In addition, Mellgren (39) identified a 
factor that could desensitize the dephosphorylation of the highly puri­
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fied substrate to glycogen inhibition (39). This factor, glycogen de-
sensitizatlon factor (GDF), was shown to be nondialyzable and heat 
sensitive. These findings led him to speculate that a factor or factors 
were responsible for the conversion of a species of bovine cardiac 
phosphorylated glycogen synthase to another species that differed in 
sensitivity to glycogen inhibition. 
Attempts to identify the GDF have not been successful. Instead, 
it was discovered that alteration in the oxidation state of the enzyme 
could effectively alter the responses of its dephosphorylation to 
glycogen inhibition (Section I). The dephosphorylation of highly 
purified cardiac phosphorylated glycogen synthase was very sensitive to 
glycogen inhibition (Figure I-l); very little glycogen (less than 0.1 
mg/ml) was able to maximally inhibit the reaction. When the same en­
zyme was aged in the absence of reducing agent, or was incubated with 
GSSG, its dephosphorylation became much less sensitive to glycogen 
inhibition. The glycogen inhibition curve for the aged enzyme (Figure 
1-2) and that for the GSSG-treated enzyme (Figure 1-5) were very similar 
to that for the partially purified enzyme (39). Treatment of the aged-
or GSSG-treated glycogen synthase with dithiothreitol reversed the ef­
fect. Their glycogen inhibition curves were similar to that for the 
freshly prepared enzyme, extremely sensitive to glycogen (Figures 1-2 
and 1-5). This suggested that oxidation of certain protein sulfhydryls 
in the glycogen synthase might be responsible for changes in the sensi­
tivity to glycogen. 
Treatment of glycogen synthase with GSSG also led to enzyme in-
activation for both the phosphorylated (Figure 1-4) and the dephosphory-
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lated (Figure II-1) enzymes. The GSSG-mediated enzyme inactivation was 
also reversible by dithiothreitol treatment (Figures 1-4 and II-l). 
GSSG-induced effects on glycogen synthase were stable, and could not 
be reversed by dialysis or gel filtration. The inactivation of glycogen 
synthase by GSSG (or other low molecular weight disulfides) was a re­
sult of formation of a protein mixed-disulfide by protein sulfhydryl-
disulfide exchange reaction (Section II). This conclusion was based on 
the fact that treatment of glycogen-free glycogen synthase I with GSSG 
resulted in the loss of protein sulfhydryls in the enzyme. Loss of a 
single protein sulfhydryl per subunit corresponded to loss of the 
majority (60-70%) of enzyme activity (Figure II-7). Only those di­
sulfides, -vrtiich oxidized protein sulfhydryls through the formation of 
mixed-disulfides, were capable of inducing the reversible enzyme in­
activation (Table II-2 and Figure II-8). There was no apparent inter-
or intra-molecular disulfide formation caused by GSSG-treatment. 
It is interesting to note that the sensitivity to glycogen inhibi­
tion was not altered unless the phosphorylated enzyme was oxidized to 
a state in which only one-third of the original enzyme activity re­
mained. Modification of glycogen synthase I by GSSG also resulted in 
loss of about two-thirds of its original enzyme activity. This sug­
gests that the formation of the protein mixed-disulfides in glycogen 
synthase may also be responsible for the changes in the sensitivity of 
its dephosphorylation to glycogen inhibition. 
It is also important to note that the partially purified bovine 
cardiac phosphorylated glycogen synthase and the homogeneous highly 
purified enzyme used in Mellgren's study (39) were isolated by dif­
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ferent purification procedures. The partially purified enzyme was 
prepared according to the method of Thomas and Larner (220), which did 
not involve the removal of glycogen from the glycogen-glycogen synthase 
complex. The preparation of the highly purified enzyme was isolated 
according to the procedure developed by Mellgren (39). In his proce­
dure, the enzyme was once made glycogen-free with a-amylase treatment 
under a very strong reducing condition. The differences between the 
partially purified enzyme and the highly purified enzyme are not 
clear. It is, however, possible that the glycogen synthase without 
glycogen under a highly reduced environment is reduced, and the de-
phosphorylation of such enzyme is very sensitive to glycogen inhibition. 
The partially purified enzyme, which has never been free of glycogen 
during the procedure, remained oxidized. The amount of glycogen 
required to inhibit dephosphorylation of such oxidized enzyme is rela­
tively high. Alternatively, it is also possible that the partially 
purified glycogen synthase may contain a factor or factors (i.e., GDF) 
that may protect the enzyme from being reduced. A protein (factor) 
has been recently suggested to protect the phosphoenolpyruvate carboxy-
kinase from reduction by reducing agents (221). 
The identity of the GDF is not certain as of now. Needless to 
say, more work on this factor(s) is necessary. There is a possibility 
that the factor itself is an enzyme that catalyzes the formation of 
protein mixed-disulfides, or that it is a very reactive disulfide-
containing substance and is capable of forming protein mixed-disulfides 
with protein sulfhydryls in a nonenzymatic process. Nevertheless, 
GDF may also act by different mechanisms to affect the sensitivity 
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of the dephosphorylation reaction to glycogen inhibition. 
It has also been reported that several homogeneous preparations of 
muscle glycogen synthase, whose purification procedures did not involve 
the removal of glycogen from the glycogen synthase, had a specific 
activity of about 10 U/mg (33, 95). The specific activity of the 
highly purified glycogen synthase isolated with the a-amylase treat­
ment (35, 39) was about three times as high. The reason for the dif­
ferent specific activities is not clear. It may simply be because dif­
ferent procedures produce different amounts of inactive enzyme co-
purified with the active enzyme. In light of the fact that the modi­
fied (oxidized) enzyme had only about one-third of the enzyme activity 
as the unmodified (reduced) enzyme species, the homogeneous muscle 
enzymes isolated without glycogen removal in the procedure may be in 
fact in the modified state (in the form of mixed-disulfides). 
It has been previously reported that treatment of rat hepatic 
phosphorylated glycogen synthase with GSSG also resulted in enzyme in-
activation (222, 223). This GSSG-mediated inactivation was also the 
result of formation of protein mixed-disulfides (222). Reaction of 
four of the eight protein sulfhydryls in each subunit of the rat liver 
enzyme through protein mixed-disulfide formation was needed to inactivate 
the enzyme. Modification of the first sulfhydryl group had no effect 
on the enzyme activity; the loss of second sulfhydryl group resulted in 
loss of the enzyme activity. Modification of the next two sulfhydryl 
groups led to the release of the enzyme from glycogen (223). Lin and 
Segal (36) had also previously observed that binding of glycogen to 
the rat liver phosphorylated glycogen synthase blocked one protein 
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sulfhydryl group from reacting with DTNB, These findings suggested a 
possible role for one or more protein sulfhydryls group in each rat 
liver phosphorylated synthase subunit in the binding of glycogen 
synthase to glycogen. In addition, glucose-6-P offered a differential 
protection against the GSSG-mediated inactivation of the hepatic enzyme. 
The oxidation of the second sulfhydryl group of the enzyme caused an 
increase in the activation constant (A^  g) for glucose-6-P of the en­
zyme (233). Although the effects of GSSG-mediated modification on the 
glycogen synthase from these two sources were slightly different, the 
effects were important for controlling the activity of the enzyme. There­
fore, the formation of the protein mixed-disulfides with GSSG may be 
inçortant in the regulation of glycogen synthesis in these tissues. 
The physiological significance of the alteration in the sensitivity 
of the glycogen synthase dephosphorylation to glycogen has been examined. 
Nuttall et al. (209) recently reported that the dephosphorylation of the 
rat heart extract glycogen synthase responded differently to glycogen 
inhibition depending on the nutritional and/or hormonal state of the 
animals. It is not clear from their studies Aether the observed dif­
ferences were due to changes in the phosphatases, the glycogen synthase, 
or both. Their data indicated that the sensitivity of the glycogen 
synthase dephosphorylation to glycogen inhibition may be subjected to 
nutritional and/or hormonal control. 
The nature of glycogen synthase phosphatases is not yet clear. 
Studies of glycogen synthase dephosphorylation with endogeneous phospha­
tases are usually confusing. Mellgren et al. (147) recently demonstrated 
that E. coli alkaline phosphatase could completely dephosphorylate the 
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purified bovine cardiac glycogen synthase. Fluoride ion is a potent 
inhibitor for the phosphoprotein phosphatases, but is ineffective for 
the E. coli alkaline phosphatase-mediated glycogen synthase dephos-
phorylation (Figure III-2). It led to an idea of using E. coli 
alkaline phosphatase to study glycogen synthase dephosphorylation in 
tissue extracts with fluoride ion to inhibit the endogeneous synthase 
phosphatase activities. There are several advantages of the utility of 
the bacterial alkaline phosphatase to study the dephosphorylation reaction 
in the extracts. With the fluoride ion, it is possible to control the 
concentrations of glycogen synthase, phosphatase, and glycogen in each 
reaction incubation. In addition, the bacterial phosphatase, unlike 
most phosphoprotein phosphatases, shows no activity on phosphorylase a 
so that any effects of phosphorylase on the dephosphorylation reaction 
will remain constant throughout the reaction. Further, since E. coli 
alkaline phosphatase is an exogeneous phosphatase and is constant in 
each reaction incubation, any effects observed are likely to be as­
sociated with the endogeneous substrates. 
In this work, the inhibitory effects of glycogen on the dephos­
phorylation of glycogen synthase in heart extracts of the rats with 
different nutritional backgrounds have been examined with E. coli alka­
line phosphatase (Section III). It was clear that the response of the 
dephosphorylation of the heart extract glycogen synthase to glycogen 
inhibition was dependent on nutritional background of the animals 
(Figure III-8), The dephosphorylation reaction in extracts of the 
fasted animals apparently was very sensitive to glycogen inhibition 
whereas the same reaction in the heart extracts of the refed animals was 
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least sensitive. The observed differences in the sensitivity to glycogen 
inhibition could not be explained by the difference in the phosphoryla­
tion states of the enzyme alone. The response to glycogen inhibition 
of the dephosphorylation reaction of the normal-fed rats and that of 
the refed animals were very different (Figure II-9), despite the fact 
that the phosphorylation state of the enzyme from extracts of these 
two groups of rats was very similar, as indicated by the similar values 
of the % glycogen synthase I and of the activation constant for glucose-
6-P of the enzyme (Table III-2). This work confirmed the findings of 
Nuttall et al. (209) and suggested that the hormonal and/or nutritional 
regulation of the glycogen synthase dephosphorylation in hearts may 
also occur through the alteration in responses to glycogen inhibition. 
Because the effects of glycogen on the dephosphorylation reaction are 
likely to be substrate-mediated, and because E. coli alkaline phospha­
tase, an exogeneous phosphatase, was used in this study, the alteration 
in the glycogen sensitivity may be a result of changes in the glycogen 
synthase molecules. 
The mechanism(s), which are responsible for the alteration of the 
sensitivity of the dephosphorylation reaction to glycogen, are yet to 
be elucidated. Many mechanisms, including the involvement of the GDF, 
are possible. However, based on the findings of this work on the 
purified cardiac enzyme, it is likely that the nutritional control of 
the dephosphorylation of the glycogen synthase in rat heart is mediated 
through the alteration of the oxidation state of glycogen synthase. In 
the fasted rat hearts, the glycogen synthase may be in the reduced state. 
The dephosphorylation of the reduced enzyme is very sensitive to glycogen 
155 
inhibition, and, thus, can be maximally inhibited by the endogeneous 
glycogen. Consequently, the enzyme exists in a highly phosphoryla ted 
state. When the fasted-rats are refed, the enzyme becomes reoxidized. 
The sensitivity of the dephosphorylation of the oxidized enzyme is 
much less sensitive to the inhibition by the endogeneous glycogen. Thus, 
the enzyme exists in a less phosphorylated state. It is also known that 
many other factors can also influence the dephosphorylation reaction, the 
possibility that it is regulated through other mechanisms cannot be ig­
nored. However, it should be noted that no other mechanism has been 
shown to affect the sensitivity of the glycogen synthase dephosphoryla­
tion to glycogen inhibition. Therefore, oxidation of glycogen synthase 
sulfhydryls remains the only known mechanism that is able to cause the 
alteration in the responses to glycogen. 
The utility of E. coli alkaline phosphatase in the glycogen syn­
thase dephosphorylation reaction may be extended to other tissue ex­
tracts. In fact, preliminary results have shown that the bacterial 
phosphatase can be used to dephosphorylate glycogen synthase in rat 
liver extracts. It is now known that there are at least two types of 
phosphoprotein phosphatase inhibitory proteins in cells (88, 90, 171-
181) . There is also evidence that there are low molecular weight heat 
stable phosphatase inhibitors in heart extracts (Figure III-l). These 
inhibitors act on both the endogeneous glycogen synthase phosphatase-
catalyzed and E. coli alkaline phosphatase-catalyzed glycogen synthase 
dephosphorylation because the heart extract enzyme could not be de-
phosphorylated by either phosphatases if these inhibitors were not 
removed. It may be possible to use the alkaline phosphatase-catalyzed 
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dephosphorylation reaction to study these inhibitors in extracts and to 
evaluate their physiological significance. It has also been shown that 
E, coli alkaline phosphatase can catalyze the dephosphorylation of 
histones (224), fibrinogen (225), acidic nuclear proteins (226) and 
ribosomal proteins (227, 228), and it seems that the enzyme may probably 
catalyze the dephosphorylation of many other phosphoproteins. Thus, 
E. coli alkaline phosphatase-catalyzed dephosphorylation reactions may 
be applied to the studies of dephosphorylation of other proteins in 
extracts. 
Because the reaction rate of the oxidation of glycogen-free bovine 
cardiac glycogen synthase with GSSG is slow, and because the concentra­
tion of GSSG required for the reaction is high while the cellular 
concentration of GSSG is low, the physiological significance of such 
slow modification may be questionable. However, it is well-known that the 
formation of protein mixed-disulfides in cells is enzyme-catalyzed. In 
fact, it has been reported that several enzymes are capable of catalyzing 
the formation of protein mixed-disulfides (229-234). The rate of the 
formation of the glycogen synthase-glutathione mixed-disulfide in heart 
may be enhanced by these enzymes. In order to confirm this hypothesis, 
identification of the enzyme(s) that catalyzes the formation of protein 
mixed-disulfides in glycogen synthase in heart is needed. On the other 
hand, the rate of reaction of bovine cardiac glycogen synthase with 
cystaminé was quite fast, and it has been reported (235) that certain 
disulfide containing peptide, i.e., insulin, can form mixed-disulfide 
with certain enzyme. The cellular oxidizing agent for the glycogen 
synthase in heart may be other disulfides, i.e., cystamine, cysteine 
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or disulfide-containing peptides rather than GSSG. 
The involvement of protein mixed-disulfides formation as a pos­
sible regulatory mechanism has recently received renewed attention. 
Mixed-disulfides between proteins and glutathione (or cysteine) were 
present in quite high intracellular concentrations. In several rat 
tissues, the concentration of protein-SSG was 25-50% of the concentration 
of total acid-soluble sulfhydryl groups (236). The level of protein-
SSG in rat liver showed a clear diurnal variation, inversely correlated 
with a variation in the level of reduced glutathione (237). These changes 
were suggested to result from diurnal variation in level of cAMP (238). 
Several functions have been suggested for the mixed-disulfides in cells. 
It has been suggested (239) that the presence of high proportion of 
intracellular glutathione in the form of protein mixed-disulfides may 
play a part in the redox buffering effect of glutathione. It has been 
suggested (240) that the protein bound glutathione may be a reservoir 
for physiological radiation protection. It has also been speculated 
(241, 242) that formation of mixed-disulfides may be involved in protein 
disulfides formation during folding of three-dimensional structure of 
proteins. Moreover, the activity of many enzymes is significantly af­
fected by the formation of protein mixed-disulfides. Table 1 lists some 
of the enzymes (or proteins) that are affected by the protein mixed-
disulfide formation. The fact that the activity of several enzymes of 
carbohydrate metabolism are altered by the formation of mixed-disulfides 
suggests that the formation of mixed-disulfides, probably in response 
to diurnal variation in cAMP level, may have regulatory importance in 
the regulation of carbohydrate metabolism. Furthermore, various 
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Table 1. Enzymes (proteins) that may be regulated through protein mixed-
disulfide formation 
Enzyme (protein) Effects References 
Hepatic phosphofructokinase Inactivation 247 
Hepatic glycogen synthase Inactivation 222, 223 
Hepatic phosphorylase phosphatase Inactivation 248 
Hepatic pyrophosphatase Inactivation 249 
Hepatic guanylate cyclase Inactivation 250 
Sarcoplasmic protein phosphatase Inactivation 251 
Adipocyte adenylate cyclase Inactivation 252 
Brain adenylate cyclase Inactivation 253 
}&iscle glyceraldehyde 3-phosphate 
dehydrogenase Inactivation 254 
Pineal indoleamlne N-acetyltrans-
ferase Inactivation 255 
eIF-2 Inactivation 256 
Formyltetrahydrofolate Inactivation 257 
L-histidine ammonia-lyase Inactivation 258 
Rhodanase Inactivation 259 
E. coll RNA. polymerase Inactivation 260 
Hepatic tyrosine aminotransferase Inactivation 261 
Pineal acetyl CoA hydrolase Activation 262 
Hepatic fructose 1,6-bisphosphatase Activation 263 
Sedoheptulose 1,7-bisphosphatase Activation 264 
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Table 1. Continued 
Enzyme (protein) Effects References 
Hepatic glutathione reductase Activation 265 
Hepatic phenylalanine hydroxylase Activation 266 
Brain opiate receptor Ligand binding decreased 267 
Tubulin Polymerization inhibition 268, 269 
Neuroblastoma cell enkephalin 
receptors 
Cluster formation 
270 
Cardiac glycogen synthase Inactivation and decreases 
in sensitivity to glyco­
gen inhibition of the de-
phosphorylation reaction This work 
membrane functions, including ion and sugar transport, mitochondrial 
functions, the release of neurotransmitters, and the action of hor­
mones, are apparently dependent upon a suitable sulfhydryl-disulfide 
balance within the proteins involved. For instance, in the lens, oxida­
tion of a portion of the GSH is accompanied by a decrease in the sodium-
potassium pump activity and by an increase in the permeability to cations, 
presumably due to alterations in the sulfhydryl-disulfide balance of 
the membrane proteins (243). The fat cell hexose transport also is in 
part dependent upon disulfide formation in the membrane, a change 
triggered either by insulin or by certain oxidants (244, 245). Further­
more, Wolosuik and Buchanan (246) have proposed a mechanism for the 
light-dependent regulation of certain enzymes involved in carbon 
dioxide assimilation, especially fructose 1,6-bisphophatase. The en­
zymes involved are reduced to active forms via a ferredoxin-thioredoxin 
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system. They are oxidized to an inactive form by GSSG, presumably 
generated via GSH peroxidase or accumulated through lower activity for 
GSSG reductase. Nevertheless, the formation of protein mixed-disulfides 
in cells must play an important physiological role and, thus, cannot be 
overlooked. 
Insulin promotes the syntheses of glycogen, protein, and lipid 
while it inhibits the degradation of these substances. Insulin is 
known to modulate a large number of cellular processes, and the evidence 
strongly suggests that its effects are triggered exclusively by its 
interaction with cell surface protein receptors. The action of insulin 
has been extensively studied ever since its discovery, but there is as 
yet no satisfactory model for the molecular mechanism for insulin action. 
Any model must account for such diverse cellular effects as the rapid 
activation of membrane glucose and amino acid transport systems, glycogen 
synthase, pyruvate dehydrogenase, and protein synthesis as well as in­
hibition of fat cell lipolysis and hepatic gluconeogenesis. Many models 
have been suggested (271). The concept that intracellular levels of 
cyclic nucleotides mediate all of the effects of insulin is now clearly 
untenable. Other plausible alternatives, including involvement of cel­
lular Ca^  influx (272) , or transmembrane electrical potential (273) 
have also been proposed. But they have as yet fallen short of providing 
a satisfying solution to the mechanism. 
Evidence accumulated to date clearly suggests that insulin action 
may affect the oxidation-reduction status of the cells especially the 
membrane proteins. Oxidants with high affinity for sulfhydryls such as 
hydrogen peroxide and diamide mimicked the stimulatory effect of insulin 
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on transport while reductants inhibited the glucose transport (271). 
It has also been reported that polyamines are able to activate fat cell 
hexose transport which is secondary to hydrogen peroxide formation 
(274), However, sulfhydryl blockade has no effect on specific binding 
of insulin-sensitive phosphodiesterase activity, but subsequent treat­
ment with hydrogen peroxide reversed the inhibitory effect of dithio-
threitol (275). It was also found that the phosphodiesterase was 
activated by hydrogen peroxide in whole cell (275). In addition, 
Mukherjee and Lynn (276), May and de Haen (277), and Little and de Haën 
(278) presented evidence that indicated that an enhancement of intra­
cellular oxidation was involved in the action of insulin. 
The effects of insulin on the protein phosphorylation-dephos-
phorylation reactions are complex, and are still unclear. Insulin 
stimulated the activation of glycogen synthase and pyruvate dehydrogenase 
by inducing the dephosphorylation of the proteins (161, 279). It has 
also been reported that insulin inhibited the endogenecus protein phos­
phorylation in intact mouse diaphragm (194). On the other hand, insulin 
increased net phosphate incorporation in other proteins, i.e., ATP-
citrate-lyase (280) and ribosomal protein S6 (281). The observed dif­
ferential effects of insulin on protein phosphorylation-dephosphorylation 
reactions, however, could not be explained simply by a general insulin-
induced effect on the phosphoprotein phosphatase, the protein kinase, 
or both. One of the plausible alternative explanations is that the ef­
fect of insulin is on the substrates. Insulin may induce changes, i.e., 
sulfhydryl modification, on the substrates such that the suitability of 
the proteins as substrates for the converting enzymes is altered. 
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On the basis of this work, I propose a model for the insulin 
action in which the insulin action is mediated through a new kind of 
protein covalent modification, namely the formation of protein mixed-
disulfides (Figure 1). Insulin, which is a disulfide-containing pep­
tide hormone, affects the target cells by interacting with the insulin 
receptors in the membrane. The binding of insulin to the receptor 
triggers the biological events. In this model, the binding of insulin 
to the membrane receptor either directly activates the coupling enzyme(s) 
to induce the biological activities (mechanism 1), or internalizes to 
produce the biological responses (mechanism 2). 
In mechanism 1, the interaction of insulin and its receptor trig­
gers the activation of the coupling enzymes, i.e., oxidoreductases, 
peroxidases, or catalase. These coupling enzymes catalyze the forma­
tion of hydrogen peroxide and/or oxidized glutathione (GSSG), resulting 
in increases in cellular oxidation state. The cellular concentration 
of oxidized glutathione is, thus, increased. Subsequently, it leads 
to the formation of protein mixed-disulfides with target enzymes by 
sulfhydryl-disulfide exchange reactions with the protein sulfhydryls and 
GSSG. This reaction is catalyzed by the mixed-disul fide forming en­
zymes. The formation of mixed-disulfides in the proteins eventually 
leads to the physiological responses. 
It is known that both insulin and its receptor (282) are disulfide-
containing molecules. It is also known that the insulin-receptor com­
plex after insulin binding is internalized for further processing (283-
285). It is still unclear whether the internalization and the degradation 
of insulin-receptor complex is necessary for the biological action or 
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Figure 1: Possible mechanism of insulin action. 
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not. In mechanism 2, I propose that the insulin-receptor complex is 
internalized. After internalization, the glutathione ;insulin 
oxidoreductase catalyzes the reduction of insulin by exchanging the 
disulfide linkage between the insulin and glutathione as such reaction 
has been demonstrated in vivo (286). The insulin-glutathione mixed-
disulfide may either exchange vith glutathione to form GSSG, which 
later will be used to oxidize the target enzymes by protein mixed-
disulfide forming enzymes, or with the target proteins directly to 
form the protein mixed-disulfides. The insulin receptor can be de­
graded to give low molecular weight peptides. Some of these peptides 
are disulfide-containing peptide since the hormone receptor itself is 
a disulfide-containing molecule. The disulfide-peptide may then inter­
act with the target enzymes to form protein mixed-disulfides. Indeed, 
both Larner's (195) and Jarett's laboratories (196) previously 
described a low molecular weight peptide(s) generated from the insulin-
treated cell membrane. This peptide is capable of activating the glyco­
gen synthase, glucose transport, and pyruvate dehydrogenase activities. 
It is possible that this peptide is a disulfide-containing peptide, and it 
is also possible that it is a degradation product of the insulin mem­
brane receptor. The formation of such protein mixed-disulfide eventually 
leads to the physiological responses of insulin. 
Although there is still no concrete evidence for this model, and 
although the model may not be able to explain all the cellular responses 
for insulin action, it is, nevertheless, a feasible mechanism for the 
insulin action. 
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